Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.1397286197193226e-33,21.394202898550724,1622.8469464593588,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS6KA6', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",6.67880971155523e-31,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.0242266437914475e-24,10.62086776859504,579.4411376057147,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'SDHC', 'NDUFC1', 'COX6B1', 'COX7A2L', 'SCO1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'NDUFS1', 'UQCRC2', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'COX15', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'COX11', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'NDUFA9', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",5.930984066308941e-22,0,0,69
3,Oxidative phosphorylation WP623,1.742026449364516e-16,12.850987432675044,466.31494496795654,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'NDUFA9', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO', 'NDUFS1']",3.402758331092021e-14,0,0,42
4,Mitochondrial complex I assembly model OXPHOS system WP4324,2.2749380242772028e-10,6.410394265232975,142.33574117416632,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'TMEM186', 'FOXRED1', 'NDUFV3', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'TIMMDC1', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'ACAD9', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'NDUFS1', 'TMEM126B']",3.332784205566102e-08,0,0,35
5,Nonalcoholic fatty liver disease WP4396,3.571230080526885e-10,3.0754318463680885,66.89968699035195,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'NDUFA12', 'COX4I1', 'PRKAG1', 'COX6A1', 'COX7C', 'BBC3', 'AKT3', 'LEPR', 'UQCRFS1', 'RAC1', 'COX8A', 'PRKAB2', 'NDUFC2', 'SDHC', 'TRAF2', 'NDUFC1', 'COX6B1', 'ERN1', 'COX7A2L', 'PIK3CA', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFS1', 'UQCRC2', 'ATF4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX5B', 'UQCRH', 'CDC42', 'NDUFV3', 'NDUFV1', 'NDUFA9', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'EIF2S1', 'NFKB1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",4.1854816543775095e-08,0,0,68
6,Mitochondrial CIV Assembly WP4922,8.789589532025561e-07,6.026843582546568,84.04148690373744,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'COX15', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'SCO2', 'COX11', 'COX14', 'SMIM20']",8.584499109611632e-05,0,0,22
7,Translation Factors WP107,1.4806286211027328e-06,3.9175220075245645,52.58506955862777,"['EIF4A2', 'EIF4A1', 'EEF1B2', 'EIF4EBP1', 'EIF4H', 'EIF4EBP2', 'EIF4B', 'EIF5B', 'EIF2B4', 'EIF2B2', 'EIF1AX', 'EIF2AK1', 'EIF2AK2', 'EIF2S2', 'EEF2', 'EIF2S1', 'EIF1', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF2S3', 'EIF6', 'EIF3I', 'EIF3J', 'ETF1', 'EIF3F', 'EIF3D', 'EIF4G3', 'EIF3A', 'EIF4G1']",0.00012394976742374306,0,0,30
8,Proteasome Degradation WP183,2.7478976433837182e-06,3.5105858275773856,44.95190858763339,"['RPN2', 'PSMD13', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'UCHL1', 'PSMD7', 'PSMB5', 'PSMD4', 'PSMB2', 'UBB', 'PSMB3', 'PSMD2', 'UBC', 'UBE2B', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMB8', 'PSMA3', 'PSMC5', 'PSMA4', 'PSMA1', 'PSMC3', 'PSMA2', 'PSME3', 'PSMC1', 'PSME1', 'PSME2']",0.00020128350237785735,0,0,32
9,Pyrimidine metabolism WP4022,7.099528250285725e-06,2.8164504033019506,33.39037767914331,"['DTYMK', 'POLD4', 'ZNRD1', 'POLR2A', 'POLR2C', 'POLR2D', 'TWISTNB', 'POLD2', 'POLR2E', 'TK2', 'POLR2G', 'POLR2I', 'POLR2K', 'POLR2L', 'DUT', 'RRM1', 'POLR3GL', 'NME2', 'CTPS2', 'CTPS1', 'NME4', 'NME1', 'DHODH', 'POLE4', 'UCK2', 'POLR3A', 'RRM2B', 'NME7', 'POLR3C', 'POLR3D', 'POLR1C', 'POLE3', 'POLR1D', 'POLR1E', 'CMPK2', 'POLR3H', 'UMPS', 'DCTPP1', 'POLR3K']",0.0004622581727408261,0,0,39
10,Photodynamic therapy-induced unfolded protein response WP3613,5.15975884890388e-05,5.471592356687898,54.015754650332134,"['XBP1', 'WARS', 'HSPA5', 'UBE2E1', 'PDIA6', 'HSP90B1', 'BBC3', 'NARS', 'ERN1', 'DDIT3', 'DNAJB11', 'DNAJB9', 'TRIB3', 'CALR', 'EIF2A', 'ATF4']",0.0030236186854576737,0,0,16
11,Ciliary landscape WP4352,0.0002783433154264624,1.6932028985507246,13.861668413325784,"['MCM9', 'MYL6B', 'SMC4', 'HSPB11', 'RPGR', 'PSMD8', 'EFTUD2', 'PSMD7', 'APMAP', 'ARHGDIA', 'BBS9', 'TMED1', 'RAC1', 'IFT57', 'BBS4', 'RAB2A', 'ZYG11B', 'EIF5B', 'NUDC', 'DYNLT1', 'EIPR1', 'DYNLL1', 'DYNLL2', 'AFG3L2', 'MYL6', 'IFT43', 'MSH2', 'TBC1D4', 'TIPRL', 'CD2BP2', 'EXOC3', 'MCM4', 'MCM6', 'EXOC2', 'PAFAH1B1', 'DDX5', 'ECHS1', 'RALB', 'PSMD13', 'VPS4A', 'COPS7B', 'COPS7A', 'EHBP1', 'EXOSC7', 'PGRMC2', 'RMND5A', 'EXOSC9', 'TCTEX1D2', 'SNRPB2', 'DCAF11', 'NDUFA9', 'DYNC1H1', 'NDUFA5', 'H3F3A', 'LCA5', 'COX6C', 'LSM4', 'NFKB1', 'AIMP1', 'COPS4', 'IFT20', 'MKLN1', 'COPS3', 'COPS6', 'IFT22', 'GID4', 'RAB14', 'MFAP1', 'WNK1', 'CNOT1', 'VAPB', 'GID8', 'CALM1', 'COPS8', 'CALM2', 'CNOT9', 'CLUAP1']",0.014828107530900634,0,0,77
12,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.001187295283970252,5.010178117048346,33.74894773133711,"['EIF5', 'EIF2S3', 'EIF1AX', 'EIF3I', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF2S1', 'EIF3D', 'EIF3A', 'EIF1']",0.057979586367213974,0,0,11
13,Mitochondrial complex III assembly WP4921,0.0014406482217004214,5.464767234800306,35.754125541986184,"['UQCRB', 'UQCC3', 'UQCC2', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRC2', 'UQCRH']",0.06493998907049592,0,0,10
14,Cytosolic DNA-sensing pathway WP4655,0.0023825433873782744,2.4975931677018632,15.08443050698458,"['NLRX1', 'POLR3GL', 'TRADD', 'ADAR', 'ISG15', 'NFKB1', 'NFKBIA', 'POLR3A', 'POLR3C', 'POLR3D', 'POLR1C', 'POLR1D', 'POLR2E', 'TRIM25', 'POLR2F', 'POLR3H', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L', 'NFKBIB']",0.09972645892883347,0,0,21
15,7q11.23 copy number variation syndrome WP4932,0.0035510863478214806,1.8599666610296426,10.491145129916703,"['BECN1', 'PCNA', 'CLTC', 'ATP5MC2', 'ATP5MC3', 'DDX21', 'UBE2L6', 'ACACB', 'FBLN5', 'ATP5MC1', 'GRIP1', 'ATP5F1A', 'ATP5F1B', 'NUP62', 'EIF4H', 'BUD23', 'SF3B1', 'PRKG1', 'EIF2A', 'MAPK3', 'ATP5PB', 'UBE2E1', 'VPS37C', 'HSPA2', 'DEK', 'ATP5F1D', 'ATP5F1E', 'MYBBP1A', 'DNAJC30', 'ATP5PO', 'GRB2', 'SQSTM1', 'GAPDH', 'VAMP2', 'ATF4', 'FBN1']",0.13872910665489252,0,0,36
16,Base Excision Repair WP4752,0.005664371522069908,2.7333163525216504,14.140974320589926,"['MBD4', 'FEN1', 'PCNA', 'PARP1', 'MPG', 'APEX2', 'LIG3', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3', 'MUTYH']",0.20745760699581037,0,0,15
17,Cellular Proteostasis WP4918,0.006469955121424203,13.64964430894309,68.80220746783793,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5']",0.22302315889144603,0,0,5
18,16p11.2 proximal deletion syndrome WP4949,0.011287422016719539,1.8463336739908023,8.279082549009921,"['PCNA', 'QPRT', 'SEZ6L2', 'PPP2CB', 'PPP4R1', 'HIRIP3', 'PPP4R4', 'CCT8', 'CCT7', 'CDIPT', 'CCT5', 'CCT4', 'MAPK3', 'CCT3', 'CCT2', 'PRRT2', 'IGFBP3', 'TRAF2', 'PPP2R5D', 'KIF22', 'NFKB1', 'CCT6A', 'TCP1', 'KCTD13', 'TMEM219', 'PPARG', 'ALDOA']",0.3674682945443139,0,0,27
19,mRNA Processing WP411,0.017358284008825914,1.5207905544147844,6.164806500427908,"['SF3B5', 'SF3B2', 'TMED10', 'SF3B3', 'DHX8', 'RNMT', 'DDX1', 'SRP54', 'CSTF2T', 'HNRNPR', 'SNU13', 'YBX1', 'EFTUD2', 'POLR2A', 'SNRPD1', 'SNRPB2', 'SNRPD3', 'TXNL4A', 'HNRNPA1', 'SF3B1', 'SF3A1', 'PRMT2', 'NCBP2', 'PRMT1', 'CPSF3', 'SUPT5H', 'CLK3', 'LSM2', 'PRPF4', 'HNRNPM', 'LSM7', 'PRPF6', 'HNRNPK', 'PHF5A', 'SNRPG', 'CD2BP2', 'SNRPE', 'SNRPA1', 'HNRNPH2', 'SNRPF', 'HNRNPC', 'DNAJC8', 'RBMX', 'SNRPB', 'SRSF9']",0.5100866867517945,0,0,45
20,Eukaryotic Transcription Initiation WP405,0.01791757132333066,2.049834310476676,8.244379090519995,"['GTF2A2', 'TAF12', 'TAF13', 'ILK', 'GTF2H3', 'POLR2A', 'POLR2C', 'POLR3D', 'POLR2E', 'POLR1D', 'POLR2F', 'POLR1E', 'TAF7', 'POLR2G', 'POLR3H', 'POLR2I', 'POLR3K', 'POLR2K']",0.5100866867517945,0,0,18
21,Synaptic Vesicle Pathway WP2267,0.01827955703376738,1.9524902539439648,7.813811220220456,"['NAPA', 'RAB3A', 'SLC32A1', 'SYT1', 'STXBP1', 'CLTC', 'CLTA', 'PARK7', 'SYP', 'AP2B1', 'SYN3', 'CPLX2', 'AP2A2', 'CPLX3', 'DNM3', 'AP2S1', 'STX3', 'SLC25A4', 'AP2M1', 'VAMP2']",0.5100866867517945,0,0,20
22,Glycolysis and Gluconeogenesis WP534,0.027948425327661217,2.2194819246435844,7.9399622522247775,"['PDHA1', 'MDH2', 'PGAM1', 'GOT2', 'SLC2A3', 'ENO2', 'GCK', 'LDHA', 'MPC2', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.7444444200913397,0,0,13
23,Methionine De Novo and Salvage Pathway WP3580,0.030272519761592828,2.730671414038657,9.550564002785187,"['AHCY', 'ADI1', 'AMD1', 'ODC1', 'MSRB2', 'SMS', 'TXN', 'MAT2B', 'SRM']",0.7712911556649303,0,0,9
24,Intraflagellar transport proteins binding to dynein WP4532,0.03660512785059126,2.184983456350216,7.226979051621828,"['DYNC2LI1', 'DYNC2H1', 'DYNC1H1', 'IFT22', 'DYNC1LI2', 'IFT43', 'DYNLT1', 'TCTEX1D2', 'WDR19', 'DYNLL1', 'DYNLL2', 'HSPB11']",0.8028268949065603,0,0,12
25,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.0366809409980427,4.549034552845528,15.036824514776272,"['ZYG11B', 'CUL2', 'ELOB', 'ELOC', 'RBX1']",0.8028268949065603,0,0,5
26,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.0366809409980427,4.549034552845528,15.036824514776272,"['UBE2N', 'UBE2V1', 'SQSTM1', 'PRKCZ', 'NFKB1']",0.8028268949065603,0,0,5
27,Myometrial relaxation and contraction pathways WP289,0.03705674067258336,1.4346068653092894,4.727467189637662,"['YWHAE', 'RYR2', 'RGS17', 'CAMK2D', 'CRCP', 'RGS14', 'YWHAB', 'RGS16', 'LPAR1', 'ITPR1', 'ATP2A2', 'ADCY3', 'ADCY8', 'PRKCZ', 'ACTG1', 'RGS4', 'RGS2', 'GNG3', 'YWHAQ', 'GNG4', 'PDE4B', 'NOS1', 'PRKACA', 'RGS7', 'YWHAH', 'GSTO1', 'IGFBP3', 'PDE4D', 'FOS', 'NFKB1', 'CREB3', 'PRKAR1A', 'MAFF', 'GNB1', 'GNB4', 'CRH', 'CALM3', 'PRKD1', 'GNB5', 'ATF5', 'CALM1', 'CALM2', 'ATF4']",0.8028268949065603,0,0,43
28,VEGFA-VEGFR2 Signaling Pathway WP3888,0.03958780348400981,1.2291245851969412,3.9691311477947115,"['RPL5', 'FHOD1', 'RPL10A', 'RPL7', 'ACTG1', 'TUBB8', 'PSMD4', 'RPL18A', 'CCND1', 'ATP6V1E1', 'EIF2A', 'TPM3', 'IGFBP3', 'SARS', 'TMEM170A', 'PDIA6', 'SND1', 'ERN1', 'KATNAL2', 'NCL', 'FSCN1', 'TFAM', 'RPL27', 'PRKD1', 'RPL26', 'ATP6V0D1', 'VCL', 'ATF4', 'LRRC59', 'SET', 'EPB41', 'PXN', 'HTRA1', 'TXN', 'PRKCZ', 'ACACB', 'STIP1', 'LDHA', 'RAP1A', 'FXR2', 'DHX36', 'PGK1', 'MYH11', 'FADD', 'MAP2K7', 'TXNDC5', 'EGR1', 'JAG1', 'SDF2L1', 'EGR3', 'IDH2', 'NFKB1', 'QKI', 'NFKBIA', 'AFDN', 'NR4A1', 'BMP2', 'TFCP2', 'CYCS', 'HYOU1', 'TPP1', 'GRB2', 'CALR', 'GRSF1', 'EIF4G2', 'EIF4G1', 'YWHAE', 'ARF4', 'FLT1', 'CLTC', 'SRP54', 'LDB2', 'PPP3CA', 'TMSB4X', 'RACK1', 'RPLP2', 'ELOC', 'RAC1', 'ACP1', 'HRAS', 'PRKG1', 'HSP90AA1', 'SSR4', 'TRPC3', 'SSR3', 'GAB1', 'SHROOM2', 'RPL13A', 'RHOA', 'EPN1', 'RCN1', 'PIK3CA', 'TKT', 'ALDOA', 'GAPDH', 'CRK', 'PTMA', 'ENG', 'NAPA', 'HDAC5', 'ROCK2', 'CAMKK2', 'CDC42', 'AP2S1', 'DNAJB9', 'RICTOR', 'ASCC3', 'CCT7', 'ABCF2', 'MAPK3', 'STAT1', 'PTPN11', 'PTPN14', 'DNAJA1', 'P4HB', 'EIF3F', 'EIF3D']",0.8028268949065603,0,0,117
29,Immune response to tuberculosis WP4197,0.044124822705384995,2.457375381485249,7.668811910054193,"['STAT1', 'IFNGR2', 'TAP1', 'IFIT1', 'PSMB8', 'IFIT3', 'PTPN2', 'IRF9', 'IFNAR1']",0.8028268949065603,0,0,9
30,Exercise-induced Circadian Regulation WP410,0.04651857935024521,1.756345362514111,5.3882980677779475,"['DAZAP2', 'HSPA8', 'GSTM3', 'BTG1', 'GSTP1', 'G0S2', 'QKI', 'DNAJA1', 'PPP2CB', 'PSMA4', 'SUMO1', 'STBD1', 'KLF9', 'CRY2', 'CRY1', 'TAB2', 'ERC2', 'EIF4G2']",0.8028268949065603,0,0,18
31,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.047392989881972415,1.7862463734023366,5.446767045573953,"['MBTPS1', 'XBP1', 'PPP1R11', 'HSPA5', 'PPP1R10', 'EIF2AK1', 'EIF2AK2', 'EIF2S1', 'ERN1', 'PPP1R2', 'PPP1R3F', 'MAP1LC3A', 'PPP1R7', 'PPP1R3E', 'DDIT3', 'PPP1R8', 'ATF4']",0.8028268949065603,0,0,17
32,RalA downstream regulated genes WP2290,0.04753612345712461,3.2755273189326557,9.978125417671087,"['CDC42', 'RALBP1', 'RAC3', 'RAC1', 'HRAS', 'EXOC2']",0.8028268949065603,0,0,6
33,RAS and bradykinin pathways in COVID-19 WP4969,0.04753612345712461,3.2755273189326557,9.978125417671087,"['SERPING1', 'NOS1', 'KLKB1', 'PRKG1', 'NFKB1', 'RHOA']",0.8028268949065603,0,0,6
34,Pilocytic astrocytoma WP2253,0.04807555680025526,5.457962915925832,16.564815962648268,"['NF1', 'BRAF', 'PTPN11', 'GRB2']",0.8028268949065603,0,0,4
35,Proximal tubule transport WP4917,0.04872161738896796,1.8624091140647432,5.627515830050493,"['ATP6V1A', 'ABCC4', 'ATP6V1G1', 'SLC22A6', 'SLC1A1', 'SLC3A1', 'SLC3A2', 'ATP1A1', 'SLC4A4', 'FXYD2', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1C1', 'ATP6V1F']",0.8028268949065603,0,0,15
36,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.04932042357787742,1.6116346644677426,4.850080776964191,"['HSPA9', 'HSPA8', 'HSPA5', 'PSMD13', 'HSPA4', 'UBE2L6', 'UBE2G2', 'HSPA2', 'UBE2J2', 'HSPA14', 'TUBA4A', 'PSMD8', 'TUBB8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMD4', 'PSMC3', 'PSMD2', 'RNF19A', 'PSMC1', 'STUB1']",0.8028268949065603,0,0,23
37,Genotoxicity pathway WP4286,0.057059271366260426,1.6956235112115112,4.8556971984378015,"['PRKAB2', 'NLRX1', 'CEBPD', 'GADD45A', 'EI24', 'SEL1L', 'PCDH8', 'ITPR1', 'CBLB', 'TRIAP1', 'TM7SF3', 'COIL', 'MEX3B', 'RPS27', 'RRM2B', 'BLOC1S2', 'ID2', 'RAPGEF2']",0.9036954870440165,0,0,18
38,Fragile X Syndrome  WP4549,0.06277423755892944,1.3848742236748388,3.8336233943392677,"['CYFIP2', 'EIF4A1', 'CLTC', 'ITPR1', 'CLTA', 'AKAP5', 'SLC6A1', 'MECP2', 'GRIP1', 'PPP3CA', 'GRM5', 'DAG1', 'AP2S1', 'EIF4EBP2', 'PRKACA', 'AP2M1', 'NTRK2', 'DUSP3', 'SLC16A1', 'HOMER1', 'KCND2', 'GAB1', 'PPP2R5B', 'BRAF', 'PTPN11', 'AP2B1', 'EEF1A1', 'ALDH3A2', 'ARHGAP32', 'ARC', 'ALDH5A1', 'PRKAR1A', 'NF1', 'GRB2', 'PLCB1', 'PTPN5', 'TELO2', 'EIF4G1', 'HCN1']",0.9680448213034908,0,0,39
39,Purine metabolism WP4792,0.06457025803867662,3.4114583333333335,9.34740052780409,"['PRPS1', 'DGUOK', 'ATIC', 'ITPA', 'APRT']",0.9702095182221667,0,0,5
40,Biomarkers for pyrimidine metabolism disorders WP4584,0.07397572589601803,2.7293519695044473,7.107282388454819,"['RRM1', 'RRM2B', 'TK2', 'CKB', 'UMPS', 'DHODH']",0.9998767371841938,0,0,6
41,Selenium Micronutrient Network WP15,0.07991617416552747,1.5726901858977331,3.9738374159420884,"['GPX4', 'TXNRD2', 'TXNRD1', 'APOA1', 'TXN', 'KMO', 'SELENOK', 'NFKB1', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX4', 'SELENOS', 'FLAD1', 'PRDX1', 'SELENOW', 'PNPO', 'SEPHS2', 'MSRB1']",0.9998767371841938,0,0,19
42,Purine metabolism and related disorders WP4224,0.08193783263817998,2.183778286295449,5.463364413737671,"['PRPS1', 'DGUOK', 'GRM5', 'ATIC', 'RRM2B', 'PFAS', 'ITPA', 'APRT']",0.9998767371841938,0,0,8
43,Type II interferon signaling (IFNG) WP619,0.08300071062637682,2.047431332655137,5.095864352542364,"['STAT1', 'IFNGR2', 'IFI6', 'HLA-B', 'TAP1', 'EIF2AK2', 'PTPN11', 'ISG15', 'IRF9']",0.9998767371841938,0,0,9
44,Unfolded protein response WP4925,0.08300071062637682,2.047431332655137,5.095864352542364,"['ERN1', 'MBTPS1', 'XBP1', 'HSPA5', 'DDIT3', 'RTCB', 'EIF2S1', 'BBC3', 'ATF4']",0.9998767371841938,0,0,9
45,Androgen receptor signaling pathway WP138,0.08697408665875762,1.4168157423971377,3.4600695650806905,"['ROCK2', 'PARK7', 'RNF4', 'CDC42', 'PSMC3IP', 'CCND1', 'SUMO1', 'KAT5', 'ZMIZ1', 'PRDX1', 'BAG1', 'RACK1', 'KAT7', 'RAC1', 'PATZ1', 'NCOA1', 'NCOA2', 'UBE2I', 'NCOA3', 'DSTN', 'RHOA', 'RUNX2', 'RHOB', 'STUB1', 'CALR', 'FKBP4', 'PLPP1', 'RAN']",0.9998767371841938,0,0,28
46,Dual hijack model of Vif in HIV infection WP3300,0.0886732851732169,3.6383032766065533,8.8148688696134,"['UBB', 'ELOB', 'ELOC', 'RBX1']",0.9998767371841938,0,0,4
47,DNA Repair Pathways Full Network WP4946,0.09178099963459868,1.3315989672638404,3.1803243647500943,"['FEN1', 'MRE11', 'DCLRE1C', 'PCNA', 'MPG', 'PRKDC', 'CETN2', 'POLD4', 'RAP1A', 'NTHL1', 'POLD2', 'REV3L', 'USP1', 'MUTYH', 'MBD4', 'XRCC6', 'PARP1', 'CENPX', 'XRCC5', 'MGMT', 'REV1', 'RPA1', 'RPA2', 'APEX2', 'LIG3', 'FANCC', 'RAD23A', 'GTF2H3', 'TERF2', 'GTF2H5', 'RBX1', 'FANCF', 'DDB1', 'POLE4', 'NEIL2', 'MSH2', 'APEX1', 'POLE3']",0.9998767371841938,0,0,38
48,GABA receptor Signaling WP4159,0.10382195839707364,1.7664870528364018,4.001230581526457,"['GABRB1', 'GABBR1', 'SLC32A1', 'GABRA6', 'GABRA4', 'GABRA3', 'AP2S1', 'AP2B1', 'SLC6A1', 'AP2A2', 'AP2M1']",0.9998767371841938,0,0,11
49,Glycosylation and related congenital defects WP4521,0.10628731617906788,1.8198931569575172,4.079489465208049,"['DPM2', 'ALG8', 'DPM3', 'MPI', 'SRD5A3', 'ALG14', 'ALG3', 'ALG13', 'MAGT1', 'ALG11']",0.9998767371841938,0,0,10
50,Cori Cycle WP1946,0.10714718636570014,2.33922671991287,5.224784088866786,"['LDHA', 'PGAM1', 'PGK1', 'TALDO1', 'ALDOA', 'GAPDH']",0.9998767371841938,0,0,6
51,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.10714718636570014,2.33922671991287,5.224784088866786,"['CDK8', 'JAG1', 'H2AFY', 'CCND1', 'CDH1', 'SOX4']",0.9998767371841938,0,0,6
52,Pregnane X receptor pathway WP2876,0.10934452829164353,2.122775800711744,4.698236877072341,"['NCOA1', 'NCOA2', 'ABCC4', 'HSP90AA1', 'PSMC5', 'DNAJC7', 'NCOA3']",0.9998767371841938,0,0,7
53,Urea cycle and metabolism of amino groups WP497,0.10934452829164353,2.122775800711744,4.698236877072341,"['ACY1', 'ODC1', 'SMS', 'PYCR1', 'PYCR3', 'CKB', 'SRM']",0.9998767371841938,0,0,7
54,PDGF Pathway WP2526,0.11484082737306693,1.5926916221033869,3.446916299180159,"['STAT1', 'PDGFA', 'PTPN11', 'FOS', 'NFKB1', 'RHOA', 'CDC42', 'NFKBIA', 'RASA1', 'ARFIP2', 'GRB2', 'RAC1', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,14
55,miR-517 relationship with ARCN1 and USP1 WP3596,0.12375050645006608,4.0924327069578466,8.551088152188077,"['ID2', 'USP1', 'ARCN1']",0.9998767371841938,0,0,3
56,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.12375050645006608,4.0924327069578466,8.551088152188077,"['RIPPLY2', 'DLL1', 'DLL3']",0.9998767371841938,0,0,3
57,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.13437114187495477,1.3987369337979094,2.8074742661845233,"['EGR1', 'CDKN1B', 'STAT1', 'PDE4D', 'ADCY3', 'BRAF', 'TTF2', 'FOS', 'TTF1', 'IGF1R', 'GNAI2', 'MYL12B', 'GNAO1', 'RAP1A', 'PIK3CA', 'APEX1', 'GNB1', 'PLCB1', 'HRAS', 'RALGDS', 'MAPK3']",0.9998767371841938,0,0,21
58,Metabolic reprogramming in colon cancer WP4290,0.1368508550910767,1.5288413547237076,3.0406569131437537,"['PDHA1', 'MDH2', 'PGAM1', 'GOT2', 'IDH2', 'PYCR1', 'TALDO1', 'PYCR2', 'PDHB', 'GLS', 'LDHA', 'PGK1', 'TKT', 'GAPDH']",0.9998767371841938,0,0,14
59,Heme Biosynthesis WP561,0.1406656549706315,2.728473456946914,5.351544472110171,"['ALAD', 'FECH', 'UROD', 'UROS']",0.9998767371841938,0,0,4
60,Mitochondrial CII Assembly WP4920,0.1406656549706315,2.728473456946914,5.351544472110171,"['SDHAF3', 'SDHAF1', 'SDHAF4', 'SDHC']",0.9998767371841938,0,0,4
61,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.14130530839800787,1.8194762267988813,3.5604100711433917,"['NFKBIA', 'PPP3CA', 'GSK3A', 'RASA1', 'DYRK1A', 'CALM1', 'CALM2', 'NFKB1']",0.9998767371841938,0,0,8
62,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.14460288530067722,1.910320284697509,3.6941086251752133,"['RAB5B', 'RAB5C', 'MRAS', 'RAB27A', 'BRAF', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,7
63,Computational Model of Aerobic Glycolysis WP4629,0.14612048265211128,2.2738821138211383,4.373411528646923,"['LDHA', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.9998767371841938,0,0,5
64,Cysteine and methionine catabolism WP4504,0.14612048265211128,2.2738821138211383,4.373411528646923,"['AHCY', 'GSS', 'ETHE1', 'SUOX', 'CDO1']",0.9998767371841938,0,0,5
65,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.14612048265211128,2.2738821138211383,4.373411528646923,"['GALNT3', 'CCND1', 'FAM20C', 'NFKB1', 'FGFR2']",0.9998767371841938,0,0,5
66,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.14612048265211128,2.2738821138211383,4.373411528646923,"['SFRP1', 'CCND1', 'NRG3', 'ERBB4', 'CDH1']",0.9998767371841938,0,0,5
67,Splicing factor NOVA regulated synaptic proteins WP4148,0.16101486067732548,1.4699026463732345,2.684422372493375,"['NTNG1', 'CADM3', 'CADM1', 'EPB41', 'APLP2', 'CLSTN1', 'ANK3', 'EFNA5', 'PRKCZ', 'DAB1', 'CDH2', 'EPB41L1', 'EPB41L3', 'MAP4']",0.9998767371841938,0,0,14
68,p53 transcriptional gene network WP4963,0.16174308956788871,1.406426651839496,2.562152224933781,"['PRKAB2', 'SIVA1', 'XRCC5', 'MGMT', 'GADD45A', 'FUCA1', 'FANCC', 'ISG15', 'PML', 'BBC3', 'RRM2B', 'MSH2', 'SESN1', 'SESN2', 'ULK2', 'BAX', 'IRF9']",0.9998767371841938,0,0,17
69,IL-18 signaling pathway WP4754,0.16378499535596328,1.1863398282002933,2.1463268656531427,"['MTCH1', 'PIGT', 'CD83', 'CD81', 'HSPB8', 'RND2', 'ELAVL1', 'ADAMTS5', 'TMSB4X', 'STMN1', 'B2M', 'ACADS', 'PARP1', 'IMP3', 'ECH1', 'NDUFC1', 'FOS', 'BPGM', 'RUNX2', 'ARFGAP2', 'ARL4D', 'RFX5', 'CLDN12', 'LTB', 'TOMM40', 'ANP32A', 'EPB41', 'RGS16', 'COX17', 'KLC1', 'ACACB', 'CENPB', 'RXRB', 'FADD', 'MAP2K7', 'ABCF1', 'MAPK3', 'MBTPS1', 'HPS1', 'DEK', 'CFLAR', 'EEF2', 'NFKB1', 'NFKBIA', 'SLC4A7', 'NR4A1', 'BMP2', 'NACA', 'SYT10', 'ZNF219', 'CYCS', 'BAX', 'HDGF', 'NFKBIE', 'AARS', 'ITM2C']",0.9998767371841938,0,0,56
70,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.16990467999712244,1.6374872838250254,2.902475202432211,"['CCND2', 'CCND1', 'CDH1', 'PDGFA', 'FGF1', 'NFKB1', 'GTPBP4', 'RUNX2', 'FGFR2']",0.9998767371841938,0,0,9
71,DNA damage response WP707,0.1761932199453856,1.3650267652306909,2.3699240412493423,"['CDKN1B', 'MRE11', 'PRKDC', 'GADD45A', 'RPA2', 'PML', 'BBC3', 'CASP9', 'CCND2', 'CDK6', 'CCND1', 'RRM2B', 'CCNE2', 'SESN1', 'CYCS', 'RAD17', 'BAX', 'ATRIP']",0.9998767371841938,0,0,18
72,Gastric acid production WP2596,0.17734692290433923,5.455699416095456,9.43643657388069,"['CCK', 'VIP']",0.9998767371841938,0,0,2
73,let-7 inhibition of ES cell reprogramming WP3299,0.17734692290433923,5.455699416095456,9.43643657388069,"['SOX2', 'EGR1']",0.9998767371841938,0,0,2
74,Nanomaterial-induced inflammasome activation WP3890,0.17734692290433923,5.455699416095456,9.43643657388069,"['NFKB1', 'CTSB']",0.9998767371841938,0,0,2
75,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.17734692290433923,5.455699416095456,9.43643657388069,"['CHRM1', 'CCKBR']",0.9998767371841938,0,0,2
76,Nucleotide metabolism WP404,0.18448065265637356,1.7364930443222257,2.9350390973359577,"['PRPS1', 'RRM1', 'RRM2B', 'MTHFD2', 'NME2', 'OAZ1', 'SRM']",0.9998767371841938,0,0,7
77,Apoptosis Modulation and Signaling WP1772,0.18486223188918469,1.3057900751078912,2.204362233967527,"['HRK', 'DFFA', 'TNFRSF6B', 'TRADD', 'FOS', 'CFLAR', 'PTPN13', 'NFKB1', 'BBC3', 'CASP9', 'NFKBIA', 'TOLLIP', 'PEA15', 'MADD', 'CYCS', 'BAX', 'BIRC6', 'PRKD1', 'FADD', 'BIRC2', 'BCL2L2', 'MAPK3']",0.9998767371841938,0,0,22
78,Ras signaling WP4223,0.18526051268874164,1.1934944478778333,2.0122224107352165,"['RAB5B', 'RAB5C', 'FLT1', 'RALB', 'RASGRF1', 'RASAL2', 'PLA2G6', 'IGF1R', 'CDC42', 'RASSF1', 'GNG10', 'GNG3', 'RAP1A', 'GNG4', 'AKT3', 'RAC3', 'RAC1', 'PRKACA', 'RALGDS', 'HRAS', 'MAPK3', 'NTRK2', 'RALBP1', 'PLA2G4C', 'GAB1', 'PTPN11', 'NFKB1', 'RHOA', 'MAPK10', 'AFDN', 'MRAS', 'PIK3CA', 'RASA1', 'GNB1', 'NF1', 'GNB4', 'CALM3', 'GRB2', 'GNB5', 'RGL1', 'CALM1', 'CALM2', 'FGFR2', 'EXOC2', 'FGFR1']",0.9998767371841938,0,0,45
79,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.1915039517709117,1.8190597204574332,3.006627101079092,"['EGLN2', 'CCND1', 'CFLAR', 'NFKB1', 'BCL2L2', 'BIRC2']",0.9998767371841938,0,0,6
80,Rett syndrome causing genes WP4312,0.19439787476923256,1.3648407643312102,2.23540215193459,"['HDAC5', 'EIF2B2', 'CDKL5', 'STXBP1', 'GABRA3', 'BRAF', 'SMARCA1', 'MECP2', 'GNAO1', 'XAB2', 'SCN8A', 'IMPDH2', 'HIVEP2', 'SCN2A', 'CRK', 'SCN1A']",0.9998767371841938,0,0,16
81,Cell Differentiation - Index expanded WP2023,0.19765246018489102,1.9488603368176538,3.1595801588852126,"['SOX2', 'HDAC5', 'ID2', 'MEF2D', 'RUNX2']",0.9998767371841938,0,0,5
82,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.19765246018489102,1.9488603368176538,3.1595801588852126,"['RYR2', 'CCKBR', 'ITPR1', 'CCK', 'PLCB1']",0.9998767371841938,0,0,5
83,Peroxiredoxin 2 induced ovarian failure WP4873,0.19942547362228966,2.728034535297105,4.398450124027979,"['MAPK10', 'STAR', 'BAX']",0.9998767371841938,0,0,3
84,Thiamine metabolic pathways WP4297,0.20154198353369387,2.1825755651511303,3.4959569211205044,"['BCKDK', 'PDHA1', 'SLC25A19', 'TKT']",0.9998767371841938,0,0,4
85,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.20568944997974545,1.5350012716174974,2.4274322409724345,"['RAB3B', 'FGD4', 'RAB3A', 'RAB4B', 'SH3TC2', 'HSPB8', 'MPZ', 'MFN2', 'SBF2']",0.9998767371841938,0,0,9
86,Oxidative Stress WP408,0.20568944997974545,1.5350012716174974,2.4274322409724345,"['MAPK10', 'NFIX', 'TXNRD2', 'TXNRD1', 'FOS', 'JUNB', 'NFKB1', 'TXN2', 'SOD1']",0.9998767371841938,0,0,9
87,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.2165718331254617,1.5592604700156187,2.3854081130255387,"['MBTPS1', 'ADAMTS2', 'CRTAP', 'BMP1', 'ITPR1', 'PLOD2', 'P4HB', 'PPIB']",0.9998767371841938,0,0,8
88,TNF-alpha signaling pathway WP231,0.2190672113201877,1.2409462345621691,1.8842238426108524,"['TRADD', 'TXN', 'PRKCZ', 'CASP9', 'PSMD2', 'RAC1', 'FADD', 'MAP2K7', 'HRAS', 'SKP1', 'MAPK3', 'HSP90AA1', 'CSNK2A1', 'TRAF2', 'CFLAR', 'NFKB1', 'NFKBIA', 'CDC37', 'MADD', 'BAX', 'GRB2', 'TAB2', 'NFKBIE', 'BIRC2', 'NFKBIB']",0.9998767371841938,0,0,25
89,miRNA regulation of DNA damage response WP1530,0.22439864882621505,1.2929417604679556,1.9320831175809468,"['CDKN1B', 'MRE11', 'PRKDC', 'GADD45A', 'RPA2', 'PML', 'BBC3', 'CASP9', 'CCND2', 'CDK6', 'CCND1', 'RRM2B', 'CCNE2', 'SESN1', 'CYCS', 'RAD17', 'BAX', 'ATRIP']",0.9998767371841938,0,0,18
90,Apoptosis WP254,0.22687437682121986,1.2696096747981946,1.8832867100345376,"['HRK', 'DFFA', 'TRADD', 'TRAF2', 'IGF1', 'CFLAR', 'NFKB1', 'IGF1R', 'BBC3', 'CASP9', 'NFKBIA', 'MAPK10', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'TNFRSF21', 'BIRC2', 'BCL2L2', 'NFKBIB']",0.9998767371841938,0,0,20
91,Melanoma WP4685,0.22687437682121986,1.2696096747981946,1.8832867100345376,"['GADD45A', 'MITF', 'BRAF', 'FOS', 'CDK6', 'CCND1', 'PIK3CA', 'CDH1', 'ERBB4', 'AKT3', 'NF1', 'BAX', 'CALM3', 'GRB2', 'RAC1', 'CALM1', 'HRAS', 'CALM2', 'VCL', 'MAPK3']",0.9998767371841938,0,0,20
92,Disruption of postsynaptic signaling by CNV WP4875,0.2533269879169863,1.3643765903307887,1.873390271226417,"['RPH3A', 'TJP1', 'RYR2', 'CAMK2D', 'DLG1', 'ARC', 'DLG2', 'HOMER1', 'NRXN3', 'DLGAP1', 'MAPK3']",0.9998767371841938,0,0,11
93,p38 MAPK Signaling Pathway WP400,0.2533269879169863,1.3643765903307887,1.873390271226417,"['CDC42', 'STAT1', 'TRADD', 'DDIT3', 'RASGRF1', 'TRAF2', 'GRB2', 'RAC1', 'HRAS', 'MEF2D', 'HMGN1']",0.9998767371841938,0,0,11
94,Parkinson's disease pathway WP2371,0.2533269879169863,1.3643765903307887,1.873390271226417,"['CASP9', 'UCHL1', 'PINK1', 'UBB', 'CCNE2', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7', 'UBE2G2', 'UBE2J2']",0.9998767371841938,0,0,11
95,Airway smooth muscle cell contraction WP4962,0.2542182558749265,1.7050940040650406,2.3352321348470686,"['ROCK2', 'PLCB1', 'CALM1', 'CALM2', 'RHOA']",0.9998767371841938,0,0,5
96,NOTCH1 regulation of endothelial cell calcification WP3413,0.2542182558749265,1.7050940040650406,2.3352321348470686,"['JAG1', 'LPAR1', 'SOX6', 'DLL1', 'DLL3']",0.9998767371841938,0,0,5
97,Pyrimidine metabolism and related diseases WP4225,0.2542182558749265,1.7050940040650406,2.3352321348470686,"['RRM1', 'RRM2B', 'TK2', 'UMPS', 'DHODH']",0.9998767371841938,0,0,5
98,Cell migration and invasion through p75NTR WP4561,0.25884652181508466,1.4551741673023137,1.966696951000012,"['NTRK2', 'ARF1', 'TRIO', 'EFNB3', 'AKT3', 'RAC1', 'EFNA5', 'RHOA']",0.9998767371841938,0,0,8
99,DNA Mismatch Repair WP531,0.25884652181508466,1.4551741673023137,1.966696951000012,"['POLE4', 'POLD4', 'PCNA', 'MSH2', 'POLD2', 'POLE3', 'RPA1', 'RPA2']",0.9998767371841938,0,0,8
100,G Protein Signaling Pathways WP35,0.26258882071319156,1.1971802591258534,1.6008286061590997,"['PDE1C', 'ITPR1', 'ADCY3', 'AKAP6', 'AKAP5', 'ADCY8', 'PRKCZ', 'GNAI2', 'PPP3CA', 'GNG10', 'GNG3', 'GNG4', 'PDE4B', 'PRKACA', 'HRAS', 'PDE4D', 'RHOA', 'GNAO1', 'GNAL', 'PRKAR1A', 'GNB1', 'PRKD1', 'GNB5', 'CALM1', 'CALM2']",0.9998767371841938,0,0,25
101,Non-homologous end joining WP438,0.2683637030831145,1.8186436372872745,2.392265877800537,"['XRCC6', 'DCLRE1C', 'PRKDC', 'XRCC5']",0.9998767371841938,0,0,4
102,Gastrin signaling pathway WP4659,0.26940062961232997,1.1698871315337693,1.5343721098857912,"['CDKN1B', 'PXN', 'ELAVL1', 'CDC42', 'CCND1', 'KAT5', 'CDH1', 'EIF4EBP1', 'RAC1', 'PRKACA', 'HRAS', 'MEF2D', 'MAPK3', 'EGR1', 'JAG1', 'PTPN11', 'FOS', 'NFKB1', 'RHOA', 'RHOB', 'NFKBIA', 'TJP1', 'BMP2', 'CCKBR', 'PIK3CA', 'GRB2', 'PPARG', 'PRKD1', 'CRK', 'BIRC2']",0.9998767371841938,0,0,30
103,Spinal Cord Injury WP2431,0.2747561037957639,1.1910042472207394,1.5386244077857687,"['EGR1', 'SEMA6A', 'CDKN1B', 'GADD45A', 'ROCK2', 'NCAN', 'OMG', 'MIF', 'FOS', 'PLA2G6', 'RHOA', 'RHOB', 'CDC42', 'NR4A1', 'PPP3CA', 'CCND1', 'COL4A1', 'PTPRA', 'APEX1', 'NOS1', 'RAC1', 'LTB', 'SLIT2', 'MAPK3']",0.9998767371841938,0,0,24
104,Alzheimer's disease WP2059,0.27611197469248605,1.2008777749425874,1.5454681995607107,"['ATP5MD', 'MME', 'PSEN2', 'ITPR1', 'ATP2A2', 'ATP2A1', 'HSD17B10', 'CASP9', 'ERN1', 'BACE1', 'PPP3CA', 'CHP1', 'CYCS', 'CALM3', 'NOS1', 'MAPT', 'FADD', 'PLCB1', 'CALM1', 'GAPDH', 'CALM2', 'MAPK3']",0.9998767371841938,0,0,22
105,DNA IR-double strand breaks and cellular response via ATM WP3959,0.27745921924854816,1.2475050045495906,1.5994028557762126,"['UPF1', 'MRE11', 'DCLRE1C', 'PCNA', 'PARP1', 'PRKDC', 'RNF8', 'TERF2', 'CASP9', 'RASSF1', 'KAT5', 'HSF1', 'NABP2', 'RAD17', 'BAX', 'MCPH1']",0.9998767371841938,0,0,16
106,G1 to S cell cycle control WP45,0.27745921924854816,1.2475050045495906,1.5994028557762126,"['CDKN2D', 'CDKN1B', 'PCNA', 'GADD45A', 'RPA1', 'RPA2', 'CREB3', 'CCND2', 'ORC6', 'CDK6', 'CCND1', 'CCNE2', 'ORC3', 'CCNG2', 'MCM4', 'MCM6']",0.9998767371841938,0,0,16
107,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.27763406911777355,1.2280652561814938,1.5737058564873383,"['PXN', 'PTPN11', 'NFKB1', 'CASP9', 'NFKBIA', 'PIK3CA', 'MSH2', 'TNIP1', 'RASA1', 'STMN1', 'EIF4EBP1', 'BAX', 'GRB2', 'NOS1', 'RAC1', 'HRAS', 'CRK', 'MAPK3']",0.9998767371841938,0,0,18
108,"Cerebral organic acidurias, including diseases WP4519",0.2824896095471108,2.0458354494667343,2.5861682297545125,"['GCDH', 'MDH2', 'IDH2']",0.9998767371841938,0,0,3
109,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.2824896095471108,2.0458354494667343,2.5861682297545125,"['AHCY', 'MAT2B', 'CDO1']",0.9998767371841938,0,0,3
110,Pentose Phosphate Metabolism WP134,0.2824896095471108,2.0458354494667343,2.5861682297545125,"['TALDO1', 'PGLS', 'TKT']",0.9998767371841938,0,0,3
111,DNA Replication WP466,0.28974808603274643,1.3049341741343068,1.616478598730329,"['POLD4', 'PCNA', 'ORC6', 'ORC3', 'UBC', 'POLD2', 'RPA1', 'RPA2', 'MCM4', 'MCM6', 'UBA52']",0.9998767371841938,0,0,11
112,Signaling of Hepatocyte Growth Factor Receptor WP313,0.28974808603274643,1.3049341741343068,1.616478598730329,"['RAP1A', 'PIK3CA', 'RASA1', 'PXN', 'GAB1', 'PTPN11', 'GRB2', 'FOS', 'HRAS', 'CRK', 'MAPK3']",0.9998767371841938,0,0,11
113,3q29 copy number variation syndrome WP4906,0.29206574618102327,1.220800472128333,1.5025323417223366,"['DYNC2H1', 'DYNLT1', 'NCBP2', 'CEP350', 'PXN', 'RNF8', 'PIGZ', 'MAD2L1BP', 'WDR53', 'FBXO45', 'DYNLL1', 'DYNLL2', 'PIGX', 'DYNC2LI1', 'DLG1', 'TCTEX1D2', 'UBE2N']",0.9998767371841938,0,0,17
114,Pathogenic Escherichia coli infection WP2272,0.29248711597281085,1.2403325151669522,1.5247837523534653,"['ROCK2', 'ARPC4', 'ARPC5', 'TUBA4A', 'RHOA', 'ACTG1', 'TUBB8', 'CDC42', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ARPC2', 'CDH1', 'ARPC3', 'NCL']",0.9998767371841938,0,0,15
115,Gene regulatory network modelling somitogenesis  WP2854,0.29299056042128446,2.7275958365067274,3.3484372559138977,"['RIPPLY2', 'DLL1']",0.9998767371841938,0,0,2
116,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.29299056042128446,2.7275958365067274,3.3484372559138977,"['SLIT2', 'RAC1']",0.9998767371841938,0,0,2
117,Vitamin B6-dependent and responsive disorders WP4228,0.29299056042128446,2.7275958365067274,3.3484372559138977,"['PNPO', 'PIGV']",0.9998767371841938,0,0,2
118,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.31400841222710396,1.5154979674796747,1.7554551003053536,"['RPH3A', 'MADD', 'RAB27A', 'GCC2', 'UNC13D']",0.9998767371841938,0,0,5
119,Transcription co-factors SKI and SKIL protein partners WP4533,0.31400841222710396,1.5154979674796747,1.7554551003053536,"['MECP2', 'PRMT5', 'ING2', 'NF1', 'TEAD1']",0.9998767371841938,0,0,5
120,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.3269842798100046,1.15447425756178,1.290521179013783,"['THRA', 'ADCY3', 'SIRT6', 'TTF2', 'TTF1', 'ADCY8', 'CASP9', 'CREB3', 'RPS6KA6', 'TBC1D4', 'PIK3CA', 'AKT3', 'ZNF516', 'PRKG2', 'PPARG', 'GRB2', 'PRKACA', 'PLCB1', 'MAP4K5', 'HRAS', 'MGLL', 'FGFR1']",0.9998767371841938,0,0,22
121,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.327244444628828,1.2922712427049312,1.4435288136168167,"['CREB3', 'CAMK2D', 'STAR', 'ITPR1', 'CALM3', 'CALM1', 'CALM2', 'CAMK1G', 'ATF4']",0.9998767371841938,0,0,9
122,The influence of laminopathies on Wnt signaling WP4844,0.327244444628828,1.2922712427049312,1.4435288136168167,"['WNT10B', 'CDK6', 'CEBPD', 'CCND1', 'FNTA', 'PPARG', 'EMD', 'TOR1AIP1', 'RUNX2']",0.9998767371841938,0,0,9
123,Cancer immunotherapy by PD-1 blockade WP4585,0.33821695816345176,1.5586922602416633,1.6897279356934036,"['PTPN11', 'HLA-A', 'PDCD1LG2', 'NFKB1']",0.9998767371841938,0,0,4
124,Homologous recombination WP186,0.33821695816345176,1.5586922602416633,1.6897279356934036,"['POLD4', 'MRE11', 'POLD2', 'RPA1']",0.9998767371841938,0,0,4
125,"NAD metabolism, sirtuins and aging WP3630",0.33821695816345176,1.5586922602416633,1.6897279356934036,"['PARP1', 'TFAM', 'PPARG', 'NFKB1']",0.9998767371841938,0,0,4
126,Serotonin and anxiety-related events WP3944,0.33821695816345176,1.5586922602416633,1.6897279356934036,"['PPP3CA', 'ARC', 'CRH', 'FOS']",0.9998767371841938,0,0,4
127,"Relationship between inflammation, COX-2 and EGFR WP4483",0.347665472502088,1.3639135959339264,1.4409945555728794,"['PIK3CA', 'PTGES2', 'AKT3', 'BRAF', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,6
128,Aryl Hydrocarbon Receptor Pathway WP2873,0.34926000997293144,1.2837379040098114,1.3504134790779088,"['NCOA1', 'HSP90AA1', 'CDKN1B', 'PTGES3', 'CDC37', 'AIP', 'BAX', 'JUNB']",0.9998767371841938,0,0,8
129,Gastric Cancer Network 2 WP2363,0.34926000997293144,1.2837379040098114,1.3504134790779088,"['OTUD5', 'AHCTF1', 'DSCC1', 'UBE2T', 'RAD17', 'BRIX1', 'CACYBP', 'CEBPZ']",0.9998767371841938,0,0,8
130,Sphingolipid pathway WP1422,0.34926000997293144,1.2837379040098114,1.3504134790779088,"['UGCG', 'ASAH1', 'SGPL1', 'GAL3ST1', 'SERINC1', 'KDSR', 'SGPP2', 'PLPP1']",0.9998767371841938,0,0,8
131,Acute viral myocarditis WP4298,0.3517809043970103,1.1595438328236494,1.2114296251582606,"['DFFA', 'CXADR', 'PARP1', 'STAT1', 'ILK', 'CASP9', 'CCND1', 'SGCB', 'RASA1', 'DAG1', 'RAC3', 'CYCS', 'BAX', 'NOS1', 'EIF4G2', 'MAPK3', 'EIF4G1']",0.9998767371841938,0,0,17
132,Calcium Regulation in the Cardiac Cell WP536,0.3614317876992453,1.0915236875800256,1.1108239522092689,"['YWHAE', 'RYR2', 'RGS17', 'CAMK2D', 'CHRM1', 'RGS14', 'YWHAB', 'RGS16', 'ITPR1', 'ATP2A2', 'ADCY3', 'ADCY8', 'PRKCZ', 'GNAI2', 'RGS4', 'RGS2', 'GNG3', 'YWHAQ', 'GNG4', 'PRKACA', 'RGS7', 'YWHAH', 'KCNB1', 'ATP2B3', 'ATP1B2', 'GNAO1', 'PRKAR1A', 'FXYD2', 'GNB1', 'GNB4', 'CALM3', 'PRKD1', 'CALR', 'GNB5', 'CALM1', 'CALM2']",0.9998767371841938,0,0,36
133,Glycogen Synthesis and Degradation WP500,0.3661889794221924,1.2003155216284986,1.205843864781026,"['GYS2', 'PPP2CB', 'GSK3A', 'PPP2R2B', 'PHKG2', 'PPP2R5B', 'PHKA1', 'PPP2R5D', 'CALM3', 'CALM1', 'CALM2']",0.9998767371841938,0,0,11
134,ATR Signaling WP3875,0.36758395964700186,1.636515997968512,1.6378309791554222,"['RPA1', 'HUS1', 'ATRIP']",0.9998767371841938,0,0,3
135,Canonical NF-KB pathway WP4562,0.36758395964700186,1.636515997968512,1.6378309791554222,"['NFKBIA', 'NFKBIE', 'NFKB1']",0.9998767371841938,0,0,3
136,"Degradation pathway of sphingolipids, including diseases WP4153",0.36758395964700186,1.636515997968512,1.6378309791554222,"['NEU3', 'HEXB', 'NEU1']",0.9998767371841938,0,0,3
137,HIF1A and PPARG regulation of glycolysis WP2456,0.36758395964700186,1.636515997968512,1.6378309791554222,"['LDHA', 'PPARG', 'GAPDH']",0.9998767371841938,0,0,3
138,Leptin and adiponectin WP3934,0.36758395964700186,1.636515997968512,1.6378309791554222,"['PRKAG1', 'LEPR', 'ADIPOR1']",0.9998767371841938,0,0,3
139,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.36758395964700186,1.636515997968512,1.6378309791554222,"['CAMK2D', 'CCND2', 'MEF2D']",0.9998767371841938,0,0,3
140,Tumor suppressor activity of SMARCB1 WP4204,0.3706144481219365,1.2275432349949136,1.2184507978653905,"['SMARCD1', 'CDK6', 'RBBP4', 'H3F3B', 'H3F3A', 'DPF2', 'ARID1A', 'ARID1B', 'GLI3']",0.9998767371841938,0,0,9
141,Physiological and pathological hypertrophy of the heart WP1528,0.37416172353903504,1.2729537366548043,1.2513990136259712,"['PPP3CA', 'CAMK2D', 'RAC1', 'FOS', 'CALM1', 'CALM2', 'RHOA']",0.9998767371841938,0,0,7
142,SARS-CoV-2 mitochondrial interactions WP5038,0.37416172353903504,1.2729537366548043,1.2513990136259712,"['TOMM70', 'NDUFB9', 'NLRX1', 'CTSL', 'ACAD9', 'PHB', 'NFKB1']",0.9998767371841938,0,0,7
143,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.37526062635554036,1.363821138211382,1.3367281368432529,"['TJP1', 'PXN', 'ITPR1', 'VCL', 'MAPK3']",0.9998767371841938,0,0,5
144,Overview of interferons-mediated signaling pathway WP4558,0.37526062635554036,1.363821138211382,1.3367281368432529,"['PIK3CA', 'STAT1', 'IFNGR2', 'IRF9', 'IFNAR1']",0.9998767371841938,0,0,5
145,Endochondral Ossification with Skeletal Dysplasias WP4808,0.37610935765169967,1.1573488899692108,1.1317429312464755,"['THRA', 'STAT1', 'IGF1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'ADAMTS5', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'CALM2', 'FGFR1']",0.9998767371841938,0,0,14
146,Endochondral Ossification WP474,0.37610935765169967,1.1573488899692108,1.1317429312464755,"['THRA', 'STAT1', 'IGF1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'ADAMTS5', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'CALM2', 'FGFR1']",0.9998767371841938,0,0,14
147,Oxidative Damage WP3941,0.38909778603413603,1.1860020129848583,1.1194964626291366,"['CDC42', 'CASP9', 'MAPK10', 'PCNA', 'CDKN1B', 'GADD45A', 'CYCS', 'TRAF2', 'NFKBIE', 'NFKB1']",0.9998767371841938,0,0,10
148,Endothelin Pathways WP2197,0.39595269691784135,1.2123061276379354,1.123153774006261,"['EDNRA', 'NPY1R', 'RIIAD1', 'ATP2A2', 'GNB5', 'PLCB1', 'CALM1', 'CALM2']",0.9998767371841938,0,0,8
149,Trans-sulfuration and one-carbon metabolism WP2525,0.39595269691784135,1.2123061276379354,1.123153774006261,"['AHCYL2', 'AHCY', 'MTHFD1', 'MTHFD2', 'GSS', 'MTHFD2L', 'AMT', 'MAT2B']",0.9998767371841938,0,0,8
150,Nucleotide Excision Repair WP4753,0.3971551488341856,1.143937651928257,1.056344368657982,"['PCNA', 'CETN2', 'RPA1', 'RPA2', 'RAD23A', 'GTF2H3', 'GTF2H5', 'RBX1', 'POLE4', 'DDB1', 'POLD4', 'POLD2', 'POLE3']",0.9998767371841938,0,0,13
151,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.40277779282692056,1.25887987489004,1.1447879086462613,"['H3F3B', 'H2AFY', 'H2AFJ', 'H2AFZ', 'H3F3A', 'MAPK3']",0.9998767371841938,0,0,6
152,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.40277779282692056,1.25887987489004,1.1447879086462613,"['LDHA', 'PDHA1', 'PRKAG1', 'KEAP1', 'PDHB', 'ACACB']",0.9998767371841938,0,0,6
153,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.40277779282692056,1.25887987489004,1.1447879086462613,"['B3GALNT1', 'UGCG', 'SGPL1', 'GALNT1', 'KDSR', 'SGPP2']",0.9998767371841938,0,0,6
154,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.4058172187100727,1.8182279766438183,1.639773302616059,"['COX8A', 'GSTP1']",0.9998767371841938,0,0,2
155,EV release from cardiac cells and their functional effects WP3297,0.4058172187100727,1.8182279766438183,1.639773302616059,"['ERBB4', 'RGS16']",0.9998767371841938,0,0,2
156,Metastatic brain tumor WP2249,0.4058172187100727,1.8182279766438183,1.639773302616059,"['CDC42', 'CDK6']",0.9998767371841938,0,0,2
157,Mitochondrial fatty acid synthesis pathway WP4317,0.4058172187100727,1.8182279766438183,1.639773302616059,"['MECR', 'HSD17B12']",0.9998767371841938,0,0,2
158,"Phase I biotransformations, non P450 WP136",0.4058172187100727,1.8182279766438183,1.639773302616059,"['ESD', 'CES2']",0.9998767371841938,0,0,2
159,The alternative pathway of fetal androgen synthesis WP4524,0.4058172187100727,1.8182279766438183,1.639773302616059,"['STAR', 'HSD17B6']",0.9998767371841938,0,0,2
160,Galanin receptor pathway WP4970,0.40849918384052003,1.363728727457455,1.2208990937113722,"['CDKN1B', 'PPARG', 'FOS', 'VAMP2']",0.9998767371841938,0,0,4
161,Hedgehog Signaling Pathway Netpath WP47,0.40849918384052003,1.363728727457455,1.2208990937113722,"['STK36', 'SAP18', 'KIF7', 'GLI3']",0.9998767371841938,0,0,4
162,NO metabolism in cystic fibrosis WP4947,0.40849918384052003,1.363728727457455,1.2208990937113722,"['PRMT5', 'PRMT2', 'PRMT1', 'NOS1']",0.9998767371841938,0,0,4
163,CAMKK2  Pathway WP4874,0.4144403891264847,1.1689797994477547,1.0296679512501974,"['FIS1', 'MAP1LC3A', 'NOS1', 'RAC1', 'CALM1', 'SQSTM1', 'CALM2', 'CAMKK2', 'MAPK3']",0.9998767371841938,0,0,9
164,Leptin signaling pathway WP2034,0.41544055655940215,1.0911502167814333,0.958483524863749,"['NCOA1', 'KHDRBS1', 'GSK3A', 'ROCK2', 'STAT1', 'PTPN11', 'ACACB', 'RHOA', 'NFKB1', 'CDC42', 'CCND1', 'CFL2', 'LEPR', 'EIF4EBP1', 'BAX', 'GRB2', 'RAC1', 'HRAS', 'MAPK3', 'SH2B1']",0.9998767371841938,0,0,20
165,Target Of Rapamycin (TOR) Signaling WP1471,0.43049348113171537,1.1364792673619943,0.9578509766809911,"['CDC42', 'PRKAB2', 'RRAGA', 'RRAGC', 'RRAGD', 'PRKAG1', 'EIF4EBP1', 'ULK2', 'RICTOR', 'RAC1']",0.9998767371841938,0,0,10
166,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.43309008195008325,1.1080861761710794,0.9272570735689386,"['EIF4A2', 'EIF4A1', 'CSNK2A1', 'MAPK10', 'PIK3CA', 'AKT3', 'EIF4EBP1', 'MAP2K7', 'PRKACA', 'EIF4G3', 'EIF4B', 'MAPK3', 'EIF4G1']",0.9998767371841938,0,0,13
167,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.43453995095692743,1.0797106068332483,0.8999035830922384,"['RALB', 'DCC', 'GADD45A', 'BRAF', 'FOS', 'RHOA', 'BBC3', 'CASP9', 'MAPK10', 'CCND1', 'MSH2', 'AKT3', 'RAC3', 'CYCS', 'BAX', 'RAC1', 'RALGDS', 'EXOC2', 'MAPK3']",0.9998767371841938,0,0,19
168,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.4363792491146484,1.2397219142645972,1.0280314338066168,"['NFKBIA', 'NLRX1', 'ITPR1', 'NFKBIE', 'NFKB1']",0.9998767371841938,0,0,5
169,Pre-implantation embryo WP3527,0.4427072372136079,1.1483934856209939,0.9357645174378915,"['SOX2', 'EGR1', 'CDH1', 'DDIT3', 'FOSB', 'SOX11', 'ATP1A1', 'ELAVL1']",0.9998767371841938,0,0,8
170,Osteoclast Signaling WP12,0.4506049123641107,1.3636363636363635,1.0870422943834077,"['AIMP2', 'ATP6V1G1', 'IFNAR1']",0.9998767371841938,0,0,3
171,Vitamin B12 Disorders WP4271,0.4506049123641107,1.3636363636363635,1.0870422943834077,"['MMAB', 'MMACHC', 'CD320']",0.9998767371841938,0,0,3
172,Canonical and non-canonical Notch signaling WP3845,0.45750767226834665,1.1688509711381376,0.9139966040980813,"['JAG1', 'MFAP1', 'PSEN2', 'DLL1', 'DLL3', 'DLK2']",0.9998767371841938,0,0,6
173,Alpha 6 Beta 4 signaling pathway WP244,0.45817064710923333,1.1157403125867011,0.8708504571601924,"['EIF4EBP1', 'GAB1', 'PTPN11', 'GRB2', 'LAMC1', 'RAC1', 'HRAS', 'RHOA', 'MAPK3']",0.9998767371841938,0,0,9
174,BDNF-TrkB Signaling WP3676,0.45817064710923333,1.1157403125867011,0.8708504571601924,"['NTRK2', 'ARC', 'TRPC3', 'HOMER1', 'EIF4EBP1', 'GAB1', 'BRAF', 'GRB2', 'HRAS']",0.9998767371841938,0,0,9
175,miRNA regulation of prostate cancer signaling pathways WP3981,0.45817064710923333,1.1157403125867011,0.8708504571601924,"['CASP9', 'NFKBIA', 'CDKN1B', 'CCND1', 'PIK3CA', 'AKT3', 'PDGFA', 'GRB2', 'NFKB1']",0.9998767371841938,0,0,9
176,Aflatoxin B1 metabolism WP699,0.4646756937465486,2.7271573604060912,2.09013580699578,['AKR7A2'],0.9998767371841938,0,0,1
177,Arylamine metabolism WP694,0.4646756937465486,2.7271573604060912,2.09013580699578,['SULT1A1'],0.9998767371841938,0,0,1
178,Omega-3/Omega-6 FA synthesis WP4723,0.47706845400471226,1.2120904241808483,0.8970624127133497,"['ACOX1', 'ACOT2', 'ACOX3', 'PLA2G6']",0.9998767371841938,0,0,4
179,Apoptosis Modulation by HSP70 WP384,0.496007849693071,1.136305894308943,0.79673624790952,"['CASP9', 'MAPK10', 'CYCS', 'FADD', 'NFKB1']",0.9998767371841938,0,0,5
180,Constitutive Androstane Receptor Pathway WP2875,0.496007849693071,1.136305894308943,0.79673624790952,"['SULT1A1', 'NCOA1', 'NCOA2', 'HSP90AA1', 'DNAJC7']",0.9998767371841938,0,0,5
181,"GPCRs, Class B Secretin-like WP334",0.496007849693071,1.136305894308943,0.79673624790952,"['ADCYAP1R1', 'VIPR2', 'ADGRE5', 'ADGRL2', 'ADGRL3']",0.9998767371841938,0,0,5
182,Nanomaterial induced apoptosis WP2507,0.496007849693071,1.136305894308943,0.79673624790952,"['CASP9', 'BAX', 'CYCS', 'CFLAR', 'FADD']",0.9998767371841938,0,0,5
183,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.5012984404289416,1.067130346322261,0.7369107725082039,"['NTRK2', 'GABRB1', 'GABRA6', 'PIK3CA', 'GABRA4', 'GABRA3', 'AP2B1', 'AP2A2', 'RHOA']",0.9998767371841938,0,0,9
184,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5090130316304338,1.3635440467123636,0.9207762878133683,"['ID2', 'RUNX2']",0.9998767371841938,0,0,2
185,Methylation Pathways WP704,0.5090130316304338,1.3635440467123636,0.9207762878133683,"['MAT2B', 'HNMT']",0.9998767371841938,0,0,2
186,miRNA Biogenesis WP2338,0.5090130316304338,1.3635440467123636,0.9207762878133683,"['XPO5', 'RAN']",0.9998767371841938,0,0,2
187,Molybdenum cofactor (Moco) biosynthesis WP4507,0.5090130316304338,1.3635440467123636,0.9207762878133683,"['SUOX', 'MOCS1']",0.9998767371841938,0,0,2
188,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5090130316304338,1.3635440467123636,0.9207762878133683,"['NFKBIA', 'NFKB1']",0.9998767371841938,0,0,2
189,Fatty Acid Biosynthesis WP357,0.5109029176130897,1.0908259212198221,0.7325721728178078,"['MECR', 'ECHS1', 'ECH1', 'ECHDC1', 'ECHDC2', 'ACACB']",0.9998767371841938,0,0,6
190,G13 Signaling Pathway WP524,0.5122650413571903,1.048862102029235,0.7015976305379797,"['CDC42', 'MAPK10', 'PIK3CA', 'ROCK2', 'CFL2', 'RAC1', 'CALM1', 'CALM2', 'RHOA', 'CIT']",0.9998767371841938,0,0,10
191,IL-1 signaling pathway WP195,0.5135403188253974,1.0318446789035025,0.6876488804117615,"['HSPB2', 'PTPN11', 'IL1RAP', 'PRKCZ', 'NFKB1', 'NFKBIA', 'TOLLIP', 'UBE2N', 'TAB2', 'UBE2V1', 'MAP2K7', 'SQSTM1', 'MAPK3', 'NFKBIB']",0.9998767371841938,0,0,14
192,Senescence and Autophagy in Cancer WP615,0.5158389920359943,1.0168367060085373,0.6731058290261249,"['GABARAPL2', 'BECN1', 'GABARAPL1', 'SPARC', 'CDKN1B', 'PCNA', 'IGFBP3', 'BRAF', 'IGF1', 'CXCL14', 'GABARAP', 'IGF1R', 'RSL1D1', 'BMP2', 'MAP1LC3B', 'ING2', 'MAP1LC3A', 'ATG16L1', 'CREG1', 'SLC39A1', 'SQSTM1', 'HRAS']",0.9998767371841938,0,0,22
193,Regulation of Microtubule Cytoskeleton WP2038,0.5221172109216573,1.0343686935158376,0.6721981225748488,"['CDC42', 'TRIO', 'PIK3CA', 'PTPRA', 'CFL2', 'DPYSL2', 'STMN1', 'TPPP', 'RAC1', 'MAPT', 'PRKACA']",0.9998767371841938,0,0,11
194,Dopamine metabolism WP2436,0.5287082430299943,1.1687223391134005,0.744848396986369,"['PPP2CB', 'PRKACA', 'SOD1']",0.9998767371841938,0,0,3
195,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.5287082430299943,1.1687223391134005,0.744848396986369,"['GABBR1', 'GRM5', 'GRM4']",0.9998767371841938,0,0,3
196,Iron metabolism in placenta WP2007,0.5287082430299943,1.1687223391134005,0.744848396986369,"['TFR2', 'FTH1', 'MCOLN1']",0.9998767371841938,0,0,3
197,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5287082430299943,1.1687223391134005,0.744848396986369,"['EDNRA', 'SPARC', 'TEAD1']",0.9998767371841938,0,0,3
198,Nanoparticle triggered regulated necrosis WP2513,0.5287082430299943,1.1687223391134005,0.744848396986369,"['PARP1', 'TRADD', 'FADD']",0.9998767371841938,0,0,3
199,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.5287082430299943,1.1687223391134005,0.744848396986369,"['UBE2N', 'UBE2V1', 'NFKB1']",0.9998767371841938,0,0,3
200,TCA cycle in senescence WP5050,0.5287082430299943,1.1687223391134005,0.744848396986369,"['PDHA1', 'ME1', 'BRAF']",0.9998767371841938,0,0,3
201,Transcriptional cascade regulating adipogenesis WP4211,0.5287082430299943,1.1687223391134005,0.744848396986369,"['CEBPD', 'DDIT3', 'PPARG']",0.9998767371841938,0,0,3
202,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5310811900559682,1.0225884448969202,0.6471352489412734,"['NFKBIA', 'DLG1', 'PIK3CA', 'CHP1', 'AHSA1', 'GRB2', 'FOS', 'MAP2K7', 'CALM1', 'CALM2', 'NFKB1', 'MAPK3']",0.9998767371841938,0,0,12
203,PDGFR-beta pathway WP3972,0.5339505545869413,1.0388289564490938,0.6518153466007269,"['PIK3CA', 'STAT1', 'RASA1', 'EIF2AK2', 'GRB2', 'FOS', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,8
204,PPAR signaling pathway WP3942,0.5393205008409501,1.0128236834448647,0.6253631861685154,"['ILK', 'APOA1', 'CPT1B', 'RXRB', 'ACADL', 'FABP5', 'ACOX1', 'FABP6', 'ME1', 'PPARG', 'ACOX3', 'SLC27A2', 'SLC27A5']",0.9998767371841938,0,0,13
205,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5422924331333043,1.090779781559563,0.6675025548151702,"['CD63', 'CD81', 'IGF1', 'SOD1']",0.9998767371841938,0,0,4
206,GDNF/RET signaling axis WP4830,0.5422924331333043,1.090779781559563,0.6675025548151702,"['SOX11', 'SLIT2', 'HSPB11', 'GLI3']",0.9998767371841938,0,0,4
207,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5422924331333043,1.090779781559563,0.6675025548151702,"['LDHA', 'PDHA1', 'PIK3CA', 'SLC2A3']",0.9998767371841938,0,0,4
208,Serotonin and anxiety WP3947,0.5422924331333043,1.090779781559563,0.6675025548151702,"['PPP3CA', 'ARC', 'CRH', 'FOS']",0.9998767371841938,0,0,4
209,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.5422924331333043,1.090779781559563,0.6675025548151702,"['CDH2', 'CDH1', 'RUNX2', 'MAPK3']",0.9998767371841938,0,0,4
210,TP53 network WP1742,0.5422924331333043,1.090779781559563,0.6675025548151702,"['SUMO1', 'GADD45A', 'BAX', 'BBC3']",0.9998767371841938,0,0,4
211,Head and Neck Squamous Cell Carcinoma WP4674,0.5441850133484987,1.001659496324658,0.6094757389565427,"['GAB1', 'KEAP1', 'NFKB1', 'IGF1R', 'CDK6', 'CCND1', 'PIK3CA', 'SESN1', 'SESN2', 'AKT3', 'EIF4EBP1', 'FAT1', 'RICTOR', 'FADD', 'HRAS', 'BIRC2', 'FGFR2', 'FGFR1']",0.9998767371841938,0,0,18
212,Genes related to primary cilium development (based on CRISPR) WP4536,0.5471485543305993,0.9948487066524879,0.5999285234620598,"['C2CD3', 'ARL6', 'ARL3', 'FBF1', 'TXNDC15', 'HSPB11', 'DYNC2LI1', 'KIF3B', 'TCTN3', 'TTC21B', 'TCTEX1D2', 'TMEM107', 'TCTN1', 'BBS9', 'KIFAP3', 'IFT57', 'BBS4', 'DYNC2H1', 'MKKS', 'DYNLT1', 'WDR19', 'DYNLL1', 'IFT20', 'TMEM17', 'IFT43', 'CEP83', 'CLUAP1']",0.9998767371841938,0,0,27
213,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.5504394639748482,0.9914561750669305,0.5919373037319936,"['RAB3A', 'RASGRF1', 'YBX1', 'ACACB', 'CDC42', 'GRIP1', 'RAP1A', 'CDH2', 'DPYSL2', 'EIF4EBP1', 'RACK1', 'KCNN2', 'RAC1', 'HRAS', 'SH2B1', 'MAPK3', 'VAV3', 'EGR1', 'NTRK2', 'CDKL5', 'CSNK2A1', 'STAT1', 'PTPN11', 'FOS', 'EIF2S2', 'EEF2', 'EIF2S1', 'NFKB1', 'NFKBIA', 'MAPK10', 'DLG1', 'BMP2', 'MARCKS', 'GRB2', 'MAPT', 'SQSTM1']",0.9998767371841938,0,0,36
214,Hippo-Yap signaling pathway WP4537,0.5530625771643244,1.0488000312695436,0.621187608225459,"['RASSF1', 'YWHAQ', 'TNIK', 'TEAD1', 'MAP4K3']",0.9998767371841938,0,0,5
215,Corticotropin-releasing hormone signaling pathway WP2355,0.5570262966119547,0.9914910389279172,0.5801638714630307,"['NCOA2', 'HSP90AA1', 'PARP1', 'BRAF', 'FOS', 'RHOA', 'NFKB1', 'GNAI2', 'CASP9', 'ERN1', 'NFKBIA', 'GNAO1', 'NR4A1', 'STAR', 'GNB1', 'CRH', 'FOSB', 'GNB5', 'JUNB', 'MAPK3']",0.9998767371841938,0,0,20
216,1q21.1 copy number variation syndrome WP4905,0.5621808357575766,1.022554002541296,0.5889212742644522,"['TJP1', 'PYGO2', 'AFDN', 'BCL9', 'PRKAB2', 'PRKAG1']",0.9998767371841938,0,0,6
217,Estrogen signaling pathway WP712,0.5621808357575766,1.022554002541296,0.5889212742644522,"['PIK3CA', 'GNB1', 'BRAF', 'FOS', 'PRKACA', 'NFKB1']",0.9998767371841938,0,0,6
218,Signal Transduction of S1P Receptor WP26,0.5621808357575766,1.022554002541296,0.5889212742644522,"['ASAH1', 'AKT3', 'MAPK6', 'PLCB1', 'GNAI2', 'MAPK3']",0.9998767371841938,0,0,6
219,Sphingolipid Metabolism (general overview) WP4725,0.5621808357575766,1.022554002541296,0.5889212742644522,"['UGCG', 'ASAH1', 'SGPL1', 'DEGS1', 'KDSR', 'SGPP2']",0.9998767371841938,0,0,6
220,RANKL/RANK signaling pathway WP2018,0.5667143019719797,0.9915083643767787,0.5630775791447772,"['CDC42', 'NFKBIA', 'STAT1', 'TRAF2', 'MITF', 'TAB2', 'RAC1', 'FOS', 'MAP2K7', 'SQSTM1', 'NFKB1', 'MAPK3']",0.9998767371841938,0,0,12
221,One-carbon metabolism WP241,0.5701948426107442,1.0045888743210338,0.5643550721481045,"['AHCYL2', 'AHCY', 'ATIC', 'MTHFD1', 'MTHFD2', 'AMT', 'MAT2B']",0.9998767371841938,0,0,7
222,Resistin as a regulator of inflammation WP4481,0.5701948426107442,1.0045888743210338,0.5643550721481045,"['NFKBIA', 'PIK3CA', 'AKT3', 'ITPR1', 'PLCB1', 'NFKB1', 'MAPK3']",0.9998767371841938,0,0,7
223,Chemokine signaling pathway WP3929,0.5806779289341423,0.9760565780504431,0.5305443521658809,"['ROCK2', 'PXN', 'ADCY3', 'ADCY8', 'CXCL14', 'PRKCZ', 'GNAI2', 'CDC42', 'GNG10', 'GNG3', 'RAP1A', 'GNG4', 'AKT3', 'RAC1', 'HRAS', 'MAPK3', 'VAV3', 'STAT1', 'BRAF', 'NFKB1', 'NFKBIA', 'PIK3CA', 'GNB1', 'GNB4', 'GRB2', 'GNB5', 'PLCB1', 'CRK', 'NFKBIB']",0.9998767371841938,0,0,29
224,NRF2 pathway WP2884,0.584416262064271,0.9736611702903838,0.522994086874675,"['HSP90AB1', 'MGST3', 'GSTP1', 'KEAP1', 'SLC2A3', 'TXN', 'SLC6A1', 'SLC5A3', 'SLC39A9', 'FTH1', 'PRDX1', 'ME1', 'SLC39A7', 'SLC39A1', 'GSTM3', 'EGR1', 'ABCC4', 'HSP90AA1', 'SLC2A13', 'TXNRD1', 'CES4A', 'MAFF', 'BLVRB', 'SQSTM1', 'CES2']",0.9998767371841938,0,0,25
225,IL-6 signaling pathway WP364,0.5901250558442085,0.9737616746011557,0.513582166768115,"['NCOA1', 'STAT1', 'GAB1', 'PTPN11', 'GRB2', 'RAC1', 'VIP', 'JUNB', 'MAPK3', 'NR2F6']",0.9998767371841938,0,0,10
226,Endometrial cancer WP4155,0.5909483966786031,0.9693757961783439,0.5099174354313472,"['GADD45A', 'ILK', 'BRAF', 'FOS', 'FGF1', 'CASP9', 'CCND1', 'PIK3CA', 'CDH1', 'AKT3', 'BAX', 'GRB2', 'HRAS', 'FGFR2', 'MAPK3', 'FGFR1']",0.9998767371841938,0,0,16
227,ATM Signaling Network in Development and Disease  WP3878,0.5958402759622687,0.9674546499220225,0.5009312238636447,"['MRE11', 'DCLRE1C', 'KAT5', 'ATMIN', 'PRKDC', 'RASGRF1', 'RNF8', 'RBBP8', 'NFKB1', 'RNF40', 'HMGN1']",0.9998767371841938,0,0,11
228,Aspirin and miRNAs WP4707,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['ABCC4', 'NFKB1']",0.9998767371841938,0,0,2
229,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['MRE11', 'DDX1']",0.9998767371841938,0,0,2
230,Estrogen metabolism WP697,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['SULT1A1', 'ARSD']",0.9998767371841938,0,0,2
231,LDLRAD4 and what we know about it WP4904,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['ATG16L1', 'LDLRAD4']",0.9998767371841938,0,0,2
232,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['CDH1', 'BAX']",0.9998767371841938,0,0,2
233,NAD Biosynthesis II (from tryptophan) WP2485,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['QPRT', 'KMO']",0.9998767371841938,0,0,2
234,Serotonin Transporter Activity WP1455,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['PPP2CB', 'NOS1']",0.9998767371841938,0,0,2
235,Sulfation Biotransformation Reaction WP692,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['SULT1A1', 'SULT4A1']",0.9998767371841938,0,0,2
236,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['NFKBIA', 'NFKB1']",0.9998767371841938,0,0,2
237,Type III interferon signaling WP2113,0.5996223315158916,1.0907336887534906,0.5578614926520513,"['STAT1', 'IRF9']",0.9998767371841938,0,0,2
238,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.6001424231485514,1.0225368207211782,0.5220953165491391,"['BMP2', 'SMURF1', 'RUNX2']",0.9998767371841938,0,0,3
239,Ganglio Sphingolipid Metabolism WP1423,0.6001424231485514,1.0225368207211782,0.5220953165491391,"['ST8SIA1', 'ST8SIA3', 'ST3GAL5']",0.9998767371841938,0,0,3
240,Glycolysis in senescence WP5049,0.6001424231485514,1.0225368207211782,0.5220953165491391,"['LDHA', 'PGK1', 'GAPDH']",0.9998767371841938,0,0,3
241,Cardiac Hypertrophic Response WP2795,0.6063147556804075,0.9578975615126328,0.47928982001086573,"['HDAC5', 'CAMK2D', 'IGF1', 'NFKB1', 'PPP3CA', 'RAC1', 'PRKD1', 'MAP2K7', 'CALM1', 'CALM2', 'PRKG1', 'FGFR2', 'MAPK3']",0.9998767371841938,0,0,13
242,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.6067356773709521,0.9737950058072009,0.4865683992804781,"['BECN1', 'MAP1LC3A', 'ATG16L1', 'ULK2', 'WIPI1']",0.9998767371841938,0,0,5
243,Kallmann's Syndrome WP5074,0.6067356773709521,0.9737950058072009,0.4865683992804781,"['PIK3CA', 'PTPN11', 'GRB2', 'ASCL1', 'FGFR1']",0.9998767371841938,0,0,5
244,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.607146733227368,0.9620828131815242,0.48006468280149506,"['YWHAE', 'RYR2', 'ADCYAP1R1', 'VIPR2', 'CHRNA4', 'YWHAB', 'ATP1A3', 'YBX1', 'ASCL1', 'HSP90B1', 'HSPD1', 'SOX2', 'MECP2', 'YWHAQ', 'TPPP', 'PRKACA', 'SCN3B', 'YWHAH', 'EGR1', 'NTRK2', 'MBD1', 'SSTR2', 'NFKB1', 'GCK', 'PRKAR1A', 'SST', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2']",0.9998767371841938,0,0,30
245,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.608339935561283,1.3634517766497463,0.6776647772836292,['VIP'],0.9998767371841938,0,0,1
246,GABA metabolism (aka GHB) WP4157,0.608339935561283,1.3634517766497463,0.6776647772836292,['AKR7A2'],0.9998767371841938,0,0,1
247,Steroid Biosynthesis WP496,0.608339935561283,1.3634517766497463,0.6776647772836292,['HSD17B1'],0.9998767371841938,0,0,1
248,16p11.2 distal deletion syndrome WP4950,0.6107344715399111,0.9623140742955378,0.4745103284466235,"['CD81', 'PRMT1', 'ATP2A1', 'TRAF2', 'GRB2', 'SH2B1']",0.9998767371841938,0,0,6
249,Fluoropyrimidine Activity WP1601,0.6107344715399111,0.9623140742955378,0.4745103284466235,"['ABCC4', 'RRM1', 'UCK2', 'GGH', 'UMPS', 'CES2']",0.9998767371841938,0,0,6
250,Sphingolipid Metabolism (integrated pathway) WP4726,0.6107344715399111,0.9623140742955378,0.4745103284466235,"['UGCG', 'ASAH1', 'SGPL1', 'DEGS1', 'KDSR', 'SGPP2']",0.9998767371841938,0,0,6
251,Neural Crest Cell Migration in Cancer WP4565,0.6188828741520254,0.9483191280027415,0.45504073160197095,"['NTRK2', 'ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1', 'FOS', 'RHOA']",0.9998767371841938,0,0,8
252,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6188828741520254,0.9483191280027415,0.45504073160197095,"['LDHA', 'PDHA1', 'SLC16A1', 'IGFBP3', 'PGK1', 'BAX', 'SLC2A3', 'HIF1AN']",0.9998767371841938,0,0,8
253,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6228912213064891,0.9437358165740668,0.4467488507564763,"['CASP9', 'DFFA', 'PARP1', 'PRKDC', 'CYCS', 'FADD', 'CFLAR', 'SPTAN1', 'ACTG1']",0.9998767371841938,0,0,9
254,Complement system WP2806,0.6306567514831547,0.937134223918575,0.4320128232566894,"['FKBP2', 'RPS19', 'SERPING1', 'APOA1', 'CD59', 'TXN', 'CALR', 'LAMC1', 'PRKACA', 'KLKB1', 'GNAI2']",0.9998767371841938,0,0,11
255,Ebola Virus Pathway on Host WP4217,0.6539405058220116,0.933385338687786,0.39644506329422385,"['CLTC', 'VPS4A', 'CLTA', 'ASGR1', 'IGF1R', 'ACTG1', 'CDC42', 'CTSL', 'RAC1', 'CTSB', 'MAPK3', 'STAT1', 'VPS33A', 'HLA-B', 'HLA-C', 'EIF2AK2', 'HLA-A', 'HLA-F', 'EIF2S1', 'NFKB1', 'RHOA', 'RHOB', 'PIK3CA', 'VPS41', 'CLEC4G']",0.9998767371841938,0,0,25
256,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6564783053405866,0.9087906504065041,0.38247875118912134,"['CASP9', 'EI24', 'SHISA5', 'BAX', 'BBC3']",0.9998767371841938,0,0,5
257,Monoamine Transport WP727,0.6564783053405866,0.9087906504065041,0.38247875118912134,"['PPP2CB', 'AMPH', 'NOS1', 'SLC6A1', 'NECTIN2']",0.9998767371841938,0,0,5
258,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6564783053405866,0.9087906504065041,0.38247875118912134,"['PARP1', 'MDH2', 'SCO2', 'GOT2', 'ELAVL1']",0.9998767371841938,0,0,5
259,Striated Muscle Contraction Pathway WP383,0.6564783053405866,0.9087906504065041,0.38247875118912134,"['TPM4', 'TPM3', 'TPM1', 'ACTG1', 'TTN']",0.9998767371841938,0,0,5
260,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6567898223049277,0.9087442806304016,0.3820281139357285,"['NFKBIA', 'STAT1', 'EIF2AK2', 'FOS', 'NFKB1', 'IRF9', 'IFNAR1']",0.9998767371841938,0,0,7
261,Neural Crest Cell Migration during Development WP4564,0.6567898223049277,0.9087442806304016,0.3820281139357285,"['ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1', 'FOS', 'RHOA']",0.9998767371841938,0,0,7
262,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6567898223049277,0.9087442806304016,0.3820281139357285,"['CASP9', 'NFKBIA', 'NDUFA13', 'HSP90AA1', 'COPS6', 'RAC1', 'AAMP']",0.9998767371841938,0,0,7
263,IL-2 signaling pathway WP49,0.6580776558268856,0.9087210780574625,0.3802382840514222,"['CCND2', 'STAT1', 'PTPN11', 'GRB2', 'FOS', 'MAPT', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,8
264,Kynurenine Pathway and links to Cellular Senescence WP5044,0.6585818423094671,0.9088138176276352,0.3795810677788945,"['EIF2AK1', 'QPRT', 'NOS1', 'KMO']",0.9998767371841938,0,0,4
265,miRNA targets in ECM and membrane receptors WP2911,0.6585818423094671,0.9088138176276352,0.3795810677788945,"['COL4A2', 'COL4A1', 'SDC2', 'LAMC1']",0.9998767371841938,0,0,4
266,Folate Metabolism WP176,0.6597665872486491,0.9086978636826043,0.3778994192593888,"['AHCY', 'GPX4', 'MTHFD1', 'FLAD1', 'MTHFD2', 'APOA1', 'NOS1', 'NFKB1', 'SOD1']",0.9998767371841938,0,0,9
267,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6597665872486491,0.9086978636826043,0.3778994192593888,"['CASP9', 'UCHL1', 'CCND1', 'COL4A2', 'PTPN11', 'GRB2', 'RAC1', 'NFKB1', 'MAPK3']",0.9998767371841938,0,0,9
268,NO/cGMP/PKG mediated Neuroprotection WP4008,0.6597665872486491,0.9086978636826043,0.3778994192593888,"['CASP9', 'NFKBIA', 'CAMK2D', 'PRKG2', 'CYCS', 'NOS1', 'CALM1', 'CALM2', 'NFKB1']",0.9998767371841938,0,0,9
269,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.6640234459821467,0.9088369730827831,0.37211222891717843,"['SFRP1', 'BMP2', 'SST']",0.9998767371841938,0,0,3
270,Genes targeted by miRNAs in adipocytes WP1992,0.6640234459821467,0.9088369730827831,0.37211222891717843,"['TMSB4X', 'IGF1', 'KCNJ2']",0.9998767371841938,0,0,3
271,IL1 and megakaryocytes in obesity WP2865,0.6640234459821467,0.9088369730827831,0.37211222891717843,"['PIK3CA', 'TIMP2', 'NFKB1']",0.9998767371841938,0,0,3
272,Overview of nanoparticle effects WP3287,0.6640234459821467,0.9088369730827831,0.37211222891717843,"['COL4A1', 'AKT3', 'BAX']",0.9998767371841938,0,0,3
273,Pancreatic adenocarcinoma pathway WP4263,0.664295731196686,0.9231566820276498,0.3775967931850121,"['RALBP1', 'RALB', 'STAT1', 'GADD45A', 'PEBP1', 'BRAF', 'RHOA', 'NFKB1', 'CASP9', 'CDC42', 'MAPK10', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'RAC3', 'BAX', 'RAC1', 'RALGDS', 'ARHGEF6', 'MAPK3']",0.9998767371841938,0,0,21
274,Autosomal recessive Osteopetrosis pathways WP4788,0.6769683804902713,0.9088601167809088,0.35457424491578715,"['OSTM1', 'NFKB1']",0.9998767371841938,0,0,2
275,Bile acids synthesis and enterohepatic circulation  WP4389,0.6769683804902713,0.9088601167809088,0.35457424491578715,"['ABCG8', 'MAPK3']",0.9998767371841938,0,0,2
276,Caloric restriction and aging WP4191,0.6769683804902713,0.9088601167809088,0.35457424491578715,"['PRKAB2', 'IGF1']",0.9998767371841938,0,0,2
277,Cell Differentiation - Index WP2029,0.6769683804902713,0.9088601167809088,0.35457424491578715,"['HDAC5', 'MEF2D']",0.9998767371841938,0,0,2
278,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.6769683804902713,0.9088601167809088,0.35457424491578715,"['STAT1', 'BLVRB']",0.9998767371841938,0,0,2
279,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.6769683804902713,0.9088601167809088,0.35457424491578715,"['RASGRF1', 'NFKB1']",0.9998767371841938,0,0,2
280,Histone Modifications WP2369,0.6946664740785753,0.8792804917077655,0.32034249523575814,"['SETD5', 'SET', 'H3F3B', 'SETD9', 'SMYD5', 'EHMT2', 'H3F3A', 'SMYD2', 'KMT5B', 'HIST1H4C']",0.9998767371841938,0,0,10
281,Amyotrophic lateral sclerosis (ALS) WP2447,0.694782901639022,0.8722908721078058,0.31764982743216424,"['CASP9', 'PPP3CA', 'CCS', 'TOMM40', 'BAX', 'NOS1', 'RAC1', 'SOD1']",0.9998767371841938,0,0,8
282,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.694782901639022,0.8722908721078058,0.31764982743216424,"['NFKBIA', 'TRAF2', 'FADD', 'RAC1', 'NFKB1', 'BIRC2', 'MAPK3', 'NFKBIB']",0.9998767371841938,0,0,8
283,Copper homeostasis WP3286,0.6952743524318608,0.8818440353240533,0.3205051208086919,"['BACE1', 'CCS', 'CCND1', 'SCO1', 'PIK3CA', 'SCO2', 'COX17', 'COX11', 'MAPT', 'ATOX1', 'SOD1']",0.9998767371841938,0,0,11
284,Autophagy WP4923,0.6958750094946867,0.8673568424458105,0.31449077052557534,"['BECN1', 'MAP1LC3B', 'PRKAB2', 'ATG16L1', 'ATG9A', 'PRKAG1', 'WIPI2']",0.9998767371841938,0,0,7
285,Melatonin metabolism and effects WP3298,0.6958750094946867,0.8673568424458105,0.31449077052557534,"['SULT1A1', 'CRY2', 'CRY1', 'CSNK1E', 'CALM1', 'CALM2', 'NFKB1']",0.9998767371841938,0,0,7
286,Nuclear receptors WP170,0.6958750094946867,0.8673568424458105,0.31449077052557534,"['RXRB', 'NR4A1', 'THRA', 'NR1H2', 'ROR1', 'PPARG', 'NR2F6']",0.9998767371841938,0,0,7
287,Prion disease pathway WP3995,0.6958750094946867,0.8673568424458105,0.31449077052557534,"['PDIA3', 'HSPA5', 'RFX5', 'NFKB1', 'HSP90B1', 'MAPK3', 'FGFR1']",0.9998767371841938,0,0,7
288,Interferon type I signaling pathways WP585,0.6961758481580154,0.8839880858206132,0.32013893296592927,"['EIF4A1', 'RAP1A', 'PRMT1', 'STAT1', 'RACK1', 'EIF4EBP1', 'PTPN11', 'RAC1', 'CRK', 'IRF9', 'EIF4B', 'IFNAR1']",0.9998767371841938,0,0,12
289,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.7015339523922611,0.8899103080722734,0.31546072847623663,"['MBTPS1', 'GSK3A', 'SEC13', 'PRKAB2', 'SEC24B', 'SAR1A', 'NR1H2', 'PRKAG1', 'CDK8', 'RBP4', 'PIK3CA', 'PPARG', 'PRKACA', 'SEC23B', 'KPNB1', 'SEC31A']",0.9998767371841938,0,0,16
290,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7019705707504575,0.8519118394308943,0.30146075892840934,"['TGFBR3', 'RUNX2', 'MAPK3', 'FBN1', 'ENG']",0.9998767371841938,0,0,5
291,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7019705707504575,0.8519118394308943,0.30146075892840934,"['BMP2', 'OMG', 'IGF1', 'ASCL1', 'SOX6']",0.9998767371841938,0,0,5
292,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7019705707504575,0.8519118394308943,0.30146075892840934,"['TRPC3', 'ITPR1', 'CA8', 'PLCB1', 'GRIA4']",0.9998767371841938,0,0,5
293,Amino Acid metabolism WP3925,0.7031330201382495,0.8909570297184977,0.3138032512989617,"['WARS', 'PDHA1', 'PPM1L', 'MDH2', 'GSS', 'ODC1', 'GOT2', 'PYCR1', 'HNMT', 'ADH5', 'GLS', 'SRM', 'LDHA', 'RARS', 'SMS', 'IARS', 'BCAT1']",0.9998767371841938,0,0,17
294,EGF/EGFR signaling pathway WP437,0.7079016727280786,0.9161412029321669,0.31648104750239625,"['NDUFA13', 'RALB', 'PCNA', 'STXBP1', 'PEBP1', 'CBLB', 'NEDD8', 'ASAP1', 'PRKCZ', 'CDC42', 'RAP1A', 'STMN1', 'EIF4EBP1', 'AP2S1', 'RICTOR', 'RAC1', 'RALGDS', 'HRAS', 'MEF2D', 'SH3GL2', 'AP2M1', 'VAV3', 'RALBP1', 'IQSEC1', 'STAT1', 'NCOA3', 'GAB1', 'BRAF', 'PTPN11', 'FOS', 'PTPN12', 'AP2B1', 'EPN1', 'RASA1', 'FOSB', 'GRB2', 'CRK', 'PTPN5']",0.9998767371841938,0,0,38
295,Ebstein-Barr virus LMP1 signaling WP262,0.7086045590135519,0.8388269084230476,0.2889403479298701,"['NFKBIA', 'HSP90AA1', 'TRADD', 'NFKB1']",0.9998767371841938,0,0,4
296,Proteoglycan biosynthesis WP4784,0.7086045590135519,0.8388269084230476,0.2889403479298701,"['CSGALNACT1', 'CANT1', 'B3GAT3', 'B4GALT7']",0.9998767371841938,0,0,4
297,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.7134562677515985,0.9088832487309645,0.3068700108766828,['NFKB1'],0.9998767371841938,0,0,1
298,Composition of Lipid Particles WP3601,0.7134562677515985,0.9088832487309645,0.3068700108766828,['APOA1'],0.9998767371841938,0,0,1
299,Effects of nitric oxide WP1995,0.7134562677515985,0.9088832487309645,0.3068700108766828,['NOS1'],0.9998767371841938,0,0,1
300,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.7134562677515985,0.9088832487309645,0.3068700108766828,['GSS'],0.9998767371841938,0,0,1
301,Hypothetical Craniofacial Development Pathway WP3655,0.7134562677515985,0.9088832487309645,0.3068700108766828,['RHOA'],0.9998767371841938,0,0,1
302,Macrophage markers WP4146,0.7134562677515985,0.9088832487309645,0.3068700108766828,['CD83'],0.9998767371841938,0,0,1
303,Sulindac Metabolic Pathway WP2542,0.7134562677515985,0.9088832487309645,0.3068700108766828,['MSRB2'],0.9998767371841938,0,0,1
304,Major receptors targeted by epinephrine and norepinephrine WP4589,0.7201098827388539,0.8178770949720671,0.2685511412619538,"['ADCY3', 'ADCY8', 'ADRA2A']",0.9998767371841938,0,0,3
305,Matrix Metalloproteinases WP129,0.7201098827388539,0.8178770949720671,0.2685511412619538,"['MMP16', 'MMP28', 'TIMP2']",0.9998767371841938,0,0,3
306,miRNAs involved in DNA damage response WP1545,0.7201098827388539,0.8178770949720671,0.2685511412619538,"['CDKN1B', 'CDK6', 'CCND1']",0.9998767371841938,0,0,3
307,Phytochemical activity on NRF2 transcriptional activation WP3,0.7201098827388539,0.8178770949720671,0.2685511412619538,"['AIMP2', 'PIK3CA', 'KEAP1']",0.9998767371841938,0,0,3
308,Circadian rhythm related genes WP3594,0.7242929654576389,0.9080194722008711,0.29289014352017634,"['DDX5', 'AHCY', 'CHRM1', 'PRKDC', 'ROCK2', 'BHLHE41', 'HEBP1', 'DBP', 'UBC', 'PRKG2', 'RPS27A', 'SKP1', 'EGR1', 'PRMT5', 'NCOA2', 'EGR3', 'HOMER1', 'KCND2', 'USP2', 'DYRK1A', 'CSNK1E', 'PML', 'NR2F6', 'SETX', 'MAPK10', 'STAR', 'MYBBP1A', 'PSPC1', 'THRAP3', 'ID2', 'CRY2', 'KLF9', 'CRH', 'CRY1', 'PPARG', 'ATF5', 'UBA52', 'ATF4']",0.9998767371841938,0,0,38
309,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.724553010453256,0.8606448674498667,0.277300078869776,"['NFKBIA', 'MAPK10', 'OTUD5', 'NLRX1', 'TKFC', 'TRADD', 'TRIM25', 'TRAF2', 'ISG15', 'FADD', 'NFKB1', 'NFKBIB']",0.9998767371841938,0,0,12
310,Modulators of TCR signaling and T cell activation WP5072,0.7248340854900961,0.8565685205379862,0.2756544552313448,"['NFKBIA', 'FIBP', 'CDKN1B', 'NDUFB10', 'DGKA', 'CBLB', 'ELOB', 'GRB2', 'RNF7', 'MEF2D', 'NFKB1']",0.9998767371841938,0,0,11
311,Toll-like Receptor Signaling Pathway WP75,0.7254765604092125,0.8697336902916726,0.2791206025237689,"['STAT1', 'FOS', 'NFKB1', 'NFKBIA', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'TAB2', 'FADD', 'RAC1', 'MAP2K7', 'IFNAR1', 'NFKBIB', 'MAPK3']",0.9998767371841938,0,0,15
312,Pathways Regulating Hippo Signaling WP4540,0.7302126831601129,0.8789726123191088,0.2763660769610894,"['NTRK2', 'PRKAB2', 'FLT1', 'PRKAG1', 'PRKCZ', 'RHOA', 'IGF1R', 'GNAI2', 'CDC42', 'GNAL', 'CDH2', 'CDH1', 'PRKAR1A', 'RAC1', 'PRKACA', 'PLCB1', 'TEAD1', 'FGFR2', 'CDH18', 'FGFR1']",0.9998767371841938,0,0,20
313,Lipid Metabolism Pathway WP3965,0.7364422052459962,0.8177382465057179,0.25016617918198497,"['PRKAB2', 'PDHA1', 'PRKAR1A', 'AKT3', 'PRKAG1', 'PRKACA']",0.9998767371841938,0,0,6
314,Oxysterols derived from cholesterol WP4545,0.7364422052459962,0.8177382465057179,0.25016617918198497,"['DBP', 'NR1H2', 'ACOT2', 'ACOT13', 'SLC27A2', 'SLC27A5']",0.9998767371841938,0,0,6
315,Tryptophan metabolism WP465,0.7364422052459962,0.8177382465057179,0.25016617918198497,"['ALDH3A2', 'GCDH', 'ECHS1', 'WARS', 'PRMT1', 'HSD17B10']",0.9998767371841938,0,0,6
316,15q11.2 copy number variation syndrome WP4940,0.7416435780959474,0.778950422514779,0.23281776872403132,"['TUBGCP2', 'TUBGCP4']",0.9998767371841938,0,0,2
317,Biotin Metabolism (including IEMs) WP5031,0.7416435780959474,0.778950422514779,0.23281776872403132,"['PCCB', 'ACACB']",0.9998767371841938,0,0,2
318,Cytosine methylation WP3585,0.7416435780959474,0.778950422514779,0.23281776872403132,"['MECP2', 'IDH2']",0.9998767371841938,0,0,2
319,EDA signaling in hair follicle development WP3930,0.7416435780959474,0.778950422514779,0.23281776872403132,"['BMP1', 'LTB']",0.9998767371841938,0,0,2
320,Trans-sulfuration pathway WP2333,0.7416435780959474,0.778950422514779,0.23281776872403132,"['AHCY', 'MAT2B']",0.9998767371841938,0,0,2
321,7-oxo-C and 7beta-HC pathways WP5064,0.7430851532302881,0.8017246532759446,0.2380678333531359,"['DBP', 'ACOT2', 'ACOT13', 'SLC27A2', 'SLC27A5']",0.9998767371841938,0,0,5
322,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7430851532302881,0.8017246532759446,0.2380678333531359,"['TTC9', 'PNCK', 'CCND1', 'ERBB4', 'TPM3']",0.9998767371841938,0,0,5
323,Nanoparticle triggered autophagic cell death WP2509,0.7430851532302881,0.8017246532759446,0.2380678333531359,"['BECN1', 'MAP1LC3A', 'ATG16L1', 'ATG9B', 'ULK2']",0.9998767371841938,0,0,5
324,Oncostatin M Signaling Pathway WP2374,0.7503000840618269,0.8434681408204829,0.24231324850126318,"['EGR1', 'CDKN1B', 'STAT1', 'PXN', 'PTPN11', 'FOS', 'NFKB1', 'NFKBIA', 'RICTOR', 'GRB2', 'JUNB', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,13
325,Regulation of toll-like receptor signaling pathway WP1449,0.7518311190840844,0.8668831168831169,0.24727282284344132,"['OTUD5', 'CUEDC2', 'STAT1', 'PELI3', 'TRAFD1', 'FOS', 'NFKB1', 'RNF41', 'NFKBIA', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'TAB2', 'FADD', 'RAC1', 'MAP2K7', 'SQSTM1', 'CTNNAL1', 'IFNAR1', 'MAPK3']",0.9998767371841938,0,0,21
326,Small cell lung cancer WP4658,0.7518311190840844,0.8668831168831169,0.24727282284344132,"['CDKN1B', 'GADD45A', 'TRAF2', 'LAMC1', 'NFKB1', 'CKS1B', 'CASP9', 'RXRB', 'NFKBIA', 'CDK6', 'CCND1', 'CCNE2', 'PIK3CA', 'COL4A2', 'COL4A1', 'AKT3', 'CYCS', 'BAX', 'BIRC2', 'SKP1', 'NFKBIB']",0.9998767371841938,0,0,21
327,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7524662587335569,0.8326972010178118,0.2368183530750621,"['NTRK2', 'PRKAB2', 'ARC', 'PIK3CA', 'HOMER1', 'AKT3', 'PRKAG1', 'EIF4EBP1', 'NF1', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,11
328,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.7530450724370213,0.7788381291048296,0.22090201106972127,"['MDH2', 'IDH2', 'IDH3B', 'SDHC']",0.9998767371841938,0,0,4
329,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.7530450724370213,0.7788381291048296,0.22090201106972127,"['STAT1', 'EIF2AK2', 'IRF9', 'IFNAR1']",0.9998767371841938,0,0,4
330,Vitamin D in inflammatory diseases WP4482,0.7530450724370213,0.7788381291048296,0.22090201106972127,"['NFKBIA', 'PPP3CA', 'DUSP1', 'NFKB1']",0.9998767371841938,0,0,4
331,Common Pathways Underlying Drug Addiction WP2636,0.7568351988137727,0.8175991861648017,0.2277911067098874,"['GRM5', 'RAP1A', 'ADCY8', 'PRKACA', 'CALM1', 'CALM2', 'ACTG1', 'MAPK3', 'GRIA4']",0.9998767371841938,0,0,9
332,ERK Pathway in Huntington's Disease WP3853,0.7686054871516794,0.7434553765178448,0.19566069889820906,"['NTRK2', 'MAP2K7', 'HRAS']",0.9998767371841938,0,0,3
333,IL-9 signaling pathway WP22,0.7686054871516794,0.7434553765178448,0.19566069889820906,"['STAT1', 'GRB2', 'MAPK3']",0.9998767371841938,0,0,3
334,NAD+ metabolism WP3644,0.7686054871516794,0.7434553765178448,0.19566069889820906,"['NT5E', 'PARP1', 'SIRT6']",0.9998767371841938,0,0,3
335,Retinoblastoma gene in cancer WP2446,0.7711272350915842,0.8421230655175609,0.21886937884591248,"['RRM1', 'CDKN1B', 'PCNA', 'PRMT2', 'H2AFZ', 'PRKDC', 'HMGB2', 'RPA1', 'RPA2', 'RABIF', 'CDK6', 'CCND1', 'CCNE2', 'RBBP4', 'STMN1', 'MCM4', 'MCM6']",0.9998767371841938,0,0,17
336,IL17 signaling pathway WP2112,0.7711926579934419,0.7787257215465602,0.20232622437865797,"['CEBPD', 'PIK3CA', 'IL17RE', 'NFKB1', 'MAPK3', 'NFKBIB']",0.9998767371841938,0,0,6
337,Metapathway biotransformation Phase I and II WP702,0.7725065495986906,0.8602179433777193,0.22203497535865793,"['GSTM3', 'GAL3ST1', 'CHST7', 'GPX4', 'GSTO1', 'NAA20', 'MGST3', 'GSTP1', 'GSS', 'AKR1A1', 'HNMT', 'NAT14', 'HS6ST2', 'HS2ST1', 'SULT1A1', 'GSTZ1', 'CYP4Z1', 'AKR7A2', 'NDST3', 'CHST10', 'CYP20A1', 'CHST1', 'NAT9', 'SULT4A1']",0.9998767371841938,0,0,24
338,MET in type 1 papillary renal cell carcinoma WP4205,0.7743375160932461,0.8237756358641595,0.2106785043540392,"['RPL11', 'GAB1', 'PTPN11', 'BRAF', 'CDC42', 'RAP1A', 'PIK3CA', 'AKT3', 'GRB2', 'RAC1', 'HRAS', 'CRK', 'MAPK3']",0.9998767371841938,0,0,13
339,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7781441577048356,0.8101162230933223,0.2032123720288496,"['VAV3', 'ERN1', 'BEX3', 'CDKN1B', 'HSPA5', 'SERBP1', 'RNF7', 'SQSTM1', 'TNFRSF21', 'NFKB1', 'HSPD1']",0.9998767371841938,0,0,11
340,Ferroptosis WP4313,0.7889810916059978,0.7786131996658312,0.1845413906777518,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'GSS', 'LPCAT3', 'VDAC2', 'SLC3A2']",0.9998767371841938,0,0,8
341,Hedgehog Signaling Pathway WP4249,0.7889810916059978,0.7786131996658312,0.1845413906777518,"['CCND2', 'CCND1', 'SMURF1', 'FBXL17', 'CSNK1E', 'PRKACA', 'KIF7', 'GLI3']",0.9998767371841938,0,0,8
342,ACE Inhibitor Pathway WP554,0.7903659096493868,0.6815989847715737,0.16035247548888246,['ATP6AP2'],0.9998767371841938,0,0,1
343,Acetylcholine Synthesis WP528,0.7903659096493868,0.6815989847715737,0.16035247548888246,['PDHA1'],0.9998767371841938,0,0,1
344,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.7903659096493868,0.6815989847715737,0.16035247548888246,['PPARG'],0.9998767371841938,0,0,1
345,FTO Obesity Variant Mechanism WP3407,0.7903659096493868,0.6815989847715737,0.16035247548888246,['ARID5B'],0.9998767371841938,0,0,1
346,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.7903659096493868,0.6815989847715737,0.16035247548888246,['ACOT2'],0.9998767371841938,0,0,1
347,SARS-CoV-2 and COVID-19 Pathway WP4846,0.7903659096493868,0.6815989847715737,0.16035247548888246,['CTSL'],0.9998767371841938,0,0,1
348,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.7903659096493868,0.6815989847715737,0.16035247548888246,['MAPK3'],0.9998767371841938,0,0,1
349,Tgif disruption of Shh signaling WP3674,0.7903659096493868,0.6815989847715737,0.16035247548888246,['GLI3'],0.9998767371841938,0,0,1
350,Vitamin D Metabolism WP1531,0.7903659096493868,0.6815989847715737,0.16035247548888246,['RXRB'],0.9998767371841938,0,0,1
351,Breast cancer pathway WP4262,0.7911590434903025,0.8568269984522924,0.20071709246531058,"['MRE11', 'CETN3', 'FGF1', 'DLL1', 'IGF1R', 'DLL3', 'FRAT2', 'CCND1', 'AKT3', 'HRAS', 'FGF22', 'SKP1', 'MAPK3', 'NCOA1', 'WNT10B', 'CSNK2A1', 'PARP1', 'GADD45A', 'NCOA3', 'BRAF', 'IGF1', 'FOS', 'CDK6', 'PIK3CA', 'CSNK2B', 'BAX', 'GRB2', 'FGFR1']",0.9998767371841938,0,0,28
352,DNA IR-damage and cellular response via ATR WP4016,0.7912647815226339,0.8270077908839377,0.19362123445806234,"['UPF1', 'FEN1', 'MRE11', 'PCNA', 'PARP1', 'PRKDC', 'XRCC5', 'RPA1', 'HUS1', 'RPA2', 'PML', 'MSH2', 'RBBP8', 'USP1', 'RAD17', 'ATRIP', 'MCPH1']",0.9998767371841938,0,0,17
353,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.792060856404243,0.7268478536957074,0.16944062834307,"['CASP9', 'BAX', 'FADD', 'BBC3']",0.9998767371841938,0,0,4
354,Mitochondrial Gene Expression WP391,0.792060856404243,0.7268478536957074,0.16944062834307,"['PPP3CA', 'TFAM', 'TFB2M', 'HCFC1']",0.9998767371841938,0,0,4
355,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.792060856404243,0.7268478536957074,0.16944062834307,"['ABCC4', 'GSTP1', 'KEAP1', 'FOS']",0.9998767371841938,0,0,4
356,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.792060856404243,0.7268478536957074,0.16944062834307,"['RASGRF1', 'ITPR1', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,4
357,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.792060856404243,0.7268478536957074,0.16944062834307,"['EGR1', 'RAP1A', 'BRAF', 'MAPK3']",0.9998767371841938,0,0,4
358,Triacylglyceride synthesis WP325,0.792060856404243,0.7268478536957074,0.16944062834307,"['AGPAT5', 'DGAT2', 'AGPAT1', 'PLPP1']",0.9998767371841938,0,0,4
359,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.7948773303428883,0.6815181518151815,0.15645440311147055,"['JAG1', 'VHL']",0.9998767371841938,0,0,2
360,Cancer immunotherapy by CTLA4 blockade WP4582,0.7948773303428883,0.6815181518151815,0.15645440311147055,"['PIK3CA', 'PTPN11']",0.9998767371841938,0,0,2
361,Osteopontin Signaling WP1434,0.7948773303428883,0.6815181518151815,0.15645440311147055,"['NFKB1', 'MAPK3']",0.9998767371841938,0,0,2
362,Peptide GPCRs WP24,0.8023933883244859,0.7432597897655077,0.16363331205558274,"['OPRD1', 'EDNRA', 'CCKBR', 'NPY1R', 'NMBR', 'SSTR2']",0.9998767371841938,0,0,6
363,Energy Metabolism WP1541,0.8053770751055589,0.7785005632881491,0.16850231694400494,"['NCOA1', 'PPP3CA', 'PRKAB2', 'MYBBP1A', 'PRMT1', 'PRKAG1', 'TFAM', 'PPARG', 'TFB2M', 'MEF2D']",0.9998767371841938,0,0,10
364,Prader-Willi and Angelman Syndrome WP3998,0.8053770751055589,0.7785005632881491,0.16850231694400494,"['CCND2', 'CDK6', 'CCND1', 'FEZ1', 'FEZ2', 'NDN', 'MKRN3', 'ATP10A', 'PRKCZ', 'BBS4']",0.9998767371841938,0,0,10
365,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8053770751055589,0.7785005632881491,0.16850231694400494,"['NFKBIA', 'MAPK10', 'TOLLIP', 'TAB2', 'IL1RAP', 'FOS', 'MAP2K7', 'NFKB1', 'MAPK3', 'NFKBIB']",0.9998767371841938,0,0,10
366,MAPK pathway in congenital thyroid cancer WP4928,0.8099989861396497,0.6814372778059928,0.14359401889777704,"['BRAF', 'FOS', 'MAPK3']",0.9998767371841938,0,0,3
367,SARS coronavirus and innate immunity WP4912,0.8099989861396497,0.6814372778059928,0.14359401889777704,"['STAT1', 'IRF9', 'IFNAR1']",0.9998767371841938,0,0,3
368,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.815057586089562,0.7516943282744593,0.15371886706380905,"['MAPK10', 'YWHAQ', 'CDH1', 'LIMD1', 'MAP4K5', 'TEAD1', 'MAP4K3', 'ACTG1']",0.9998767371841938,0,0,8
369,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.815057586089562,0.7516943282744593,0.15371886706380905,"['LARP1', 'STAT1', 'TRADD', 'TRIM25', 'TRAF2', 'FADD', 'NFKB1', 'IFNAR1']",0.9998767371841938,0,0,8
370,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8217437472534753,0.7336435806186696,0.1440338052057221,"['NFKBIA', 'PIK3CA', 'STAT1', 'EIF4EBP1', 'PTPN11', 'NFKB1', 'MAPK3']",0.9998767371841938,0,0,7
371,Osteoblast differentiation WP4787,0.8240346338049211,0.8129969890410229,0.15734964750456845,"['WNT10B', 'JAG1', 'PRKDC', 'STAT1', 'WNT8A', 'FGF1', 'PRKCZ', 'DLL1', 'RUNX2', 'GLI3', 'DLL3', 'MAPK10', 'BMP2', 'PIK3CA', 'PPARG', 'PRKD1', 'MAPK6', 'FGFR2', 'FGFR1', 'MAPK3']",0.9998767371841938,0,0,20
372,Vitamin D Receptor Pathway WP2877,0.8240346338049211,0.8129969890410229,0.15734964750456845,"['CDKN2D', 'CDKN1B', 'GADD45A', 'IGFBP3', 'TPM1', 'MED9', 'G0S2', 'GXYLT2', 'EFNA5', 'ADAMTS5', 'SFRP1', 'CEACAM1', 'CCND1', 'ADGRE5', 'PNOC', 'CREG2', 'TIMP2', 'CLPTM1L', 'JUNB', 'CD200']",0.9998767371841938,0,0,20
373,Integrin-mediated Cell Adhesion WP185,0.8250600612555513,0.8085718383477818,0.15548763176665062,"['VAV3', 'ROCK2', 'PXN', 'ILK', 'BRAF', 'ITGAE', 'CDC42', 'MAPK10', 'RAP1A', 'ITGA10', 'AKT3', 'CAPN5', 'RAC3', 'GRB2', 'RAC1', 'MAPK6', 'HRAS', 'CRK', 'VCL']",0.9998767371841938,0,0,19
374,Urea cycle and associated pathways WP4595,0.8259564382635519,0.6813563627127254,0.1302843611372178,"['MDH2', 'GOT2', 'PYCR1', 'NOS1']",0.9998767371841938,0,0,4
375,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8301807476570493,0.7108778520523727,0.13230278053814856,"['NFKBIA', 'HDAC5', 'PPP3CA', 'SUPT4H1', 'SUPT5H', 'NFKB1']",0.9998767371841938,0,0,6
376,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8333044905973715,0.8701031729883063,0.15866868097905937,"['CDKN1B', 'CHRM1', 'FLT1', 'HSP90AB1', 'CAB39L', 'SLC2A3', 'ITGAE', 'LAMC1', 'FGF1', 'ELAVL1', 'IGF1R', 'GYS2', 'GHR', 'CASP9', 'AKT3', 'NOS1', 'HRAS', 'RAB2A', 'HSP90AA1', 'PPP2R5B', 'PPP2R5D', 'CREB3', 'COL4A2', 'PIK3CA', 'COL4A1', 'CDC37', 'EIF4E2', 'ATF4', 'IFNAR1', 'LPAR1', 'PDGFA', 'EFNA5', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'RELN', 'GNG4', 'PPP2R3C', 'PDGFC', 'EIF4EBP1', 'FGF22', 'EIF4B', 'MAPK3', 'IGF1', 'RAB14', 'PIK3IP1', 'PPP2R2B', 'ITGA10', 'GNB1', 'GNB4', 'GRB2', 'FGF12', 'FGFR2', 'FGFR1']",0.9998767371841938,0,0,55
377,Neural Crest Differentiation WP2064,0.8338168148790512,0.7782749463421732,0.1414448928774757,"['HDAC5', 'HDAC11', 'WNT8A', 'MITF', 'ASCL1', 'DLL1', 'NFKB1', 'RHOB', 'DLL3', 'CDH2', 'CDH1', 'MPZ', 'FGFR2', 'FGFR1']",0.9998767371841938,0,0,14
378,Insulin Signaling WP481,0.8343353670523374,0.8431661750245821,0.15271412160399103,"['ARF1', 'GSK3A', 'STXBP3', 'STXBP4', 'STXBP1', 'CBLB', 'PRKCZ', 'IGF1R', 'GYS2', 'RPS6KA6', 'EIF4EBP1', 'RAC1', 'MAP2K7', 'MAP4K5', 'MAPK6', 'HRAS', 'MAP4K3', 'MAPK3', 'CAP1', 'EGR1', 'XBP1', 'GAB1', 'PTPN11', 'FOS', 'MAPK10', 'TBC1D4', 'PIK3CA', 'TRIB3', 'GRB2', 'SGK3', 'MAP3K13', 'SGK2', 'CRK', 'PFKM', 'VAMP2']",0.9998767371841938,0,0,35
379,AMP-activated protein kinase (AMPK) signaling WP1403,0.8365795604809564,0.7698352962011866,0.1373645232806161,"['PRKAB2', 'PRKAG1', 'ADIPOR1', 'EEF2', 'ELAVL1', 'CPT1B', 'ACACB', 'CAMKK2', 'GYS2', 'PIK3CA', 'LEPR', 'EIF4EBP1', 'PLCB1']",0.9998767371841938,0,0,13
380,Alanine and aspartate metabolism WP106,0.8381516714215899,0.6057374968266057,0.10694671228923851,"['DARS', 'GOT2']",0.9998767371841938,0,0,2
381,Development and heterogeneity of the ILC family WP3893,0.8381516714215899,0.6057374968266057,0.10694671228923851,"['ID2', 'TOX']",0.9998767371841938,0,0,2
382,Disorders of Folate Metabolism and Transport WP4259,0.8381516714215899,0.6057374968266057,0.10694671228923851,"['ATIC', 'MTHFD1']",0.9998767371841938,0,0,2
383,Glutathione metabolism WP100,0.8381516714215899,0.6057374968266057,0.10694671228923851,"['GPX4', 'GSS']",0.9998767371841938,0,0,2
384,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.8381516714215899,0.6057374968266057,0.10694671228923851,"['NFKBIA', 'NFKB1']",0.9998767371841938,0,0,2
385,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.8381516714215899,0.6057374968266057,0.10694671228923851,"['NFKB1', 'SOX4']",0.9998767371841938,0,0,2
386,Neuroinflammation WP4919,0.8381516714215899,0.6057374968266057,0.10694671228923851,"['NFKBIA', 'FOS']",0.9998767371841938,0,0,2
387,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.8381516714215899,0.6057374968266057,0.10694671228923851,"['ADAR', 'SAMHD1']",0.9998767371841938,0,0,2
388,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.8381516714215899,0.6057374968266057,0.10694671228923851,"['STAG1', 'ANAPC11']",0.9998767371841938,0,0,2
389,Aryl Hydrocarbon Receptor Netpath WP2586,0.8385845102363797,0.7265700483091787,0.12790532983348304,"['HSP90AA1', 'CDKN1B', 'CDC37', 'AIP', 'NF1', 'NCOA7', 'HRAS', 'NFKB1']",0.9998767371841938,0,0,8
390,Integrated Cancer Pathway WP1971,0.8385845102363797,0.7265700483091787,0.12790532983348304,"['CASP9', 'MRE11', 'CDKN1B', 'POU2F1', 'MSH2', 'STAT1', 'BAX', 'BBC3']",0.9998767371841938,0,0,8
391,AGE/RAGE pathway WP2324,0.8398179950499616,0.7602147419013063,0.13271075072931413,"['CASP9', 'CDC42', 'NFKBIA', 'STAT1', 'CYCS', 'RAC1', 'PRKCZ', 'DDOST', 'RHOA', 'NFKB1', 'MAPK3', 'SOD1']",0.9998767371841938,0,0,12
392,Nuclear Receptors Meta-Pathway WP2882,0.8401421155777233,0.861123852837935,0.149994183395078,"['CDKN1B', 'HSP90AB1', 'KEAP1', 'SLC2A3', 'SLC6A1', 'RGS2', 'CCND1', 'SLC39A9', 'FTH1', 'PDE4B', 'ME1', 'SLC39A7', 'JUNB', 'SLC39A1', 'NCOA1', 'NCOA2', 'ABCG8', 'ABCC4', 'HSP90AA1', 'NCOA3', 'SLC2A13', 'AIP', 'APOA1', 'CES4A', 'TGFBR3', 'DNAJC7', 'NAV3', 'ACOX1', 'CDC37', 'BLVRB', 'SQSTM1', 'CES2', 'SLC27A5', 'BIRC2', 'MGST3', 'GSTP1', 'TXN', 'SLC5A3', 'SULT1A1', 'FGD4', 'PRDX1', 'EGR1', 'GSTM3', 'PLK2', 'PTGES3', 'TXNRD1', 'SMARCA1', 'PSMC5', 'MAFF', 'BAX']",0.9998767371841938,0,0,50
393,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8423687719038283,0.7906720498630903,0.13562981917781253,"['GAB1', 'PDGFA', 'BRAF', 'IGF1', 'IGF1R', 'MRAS', 'CCND1', 'PIK3CA', 'AKT3', 'PDGFC', 'EIF4EBP1', 'NF1', 'BAX', 'GRB2', 'EIF4E2', 'HRAS', 'FGFR2', 'MAPK3']",0.9998767371841938,0,0,18
394,PI3K-Akt signaling pathway WP4172,0.8440992322453077,0.8663518574987487,0.14683383304048106,"['CDKN1B', 'CHRM1', 'FLT1', 'HSP90AB1', 'LAMC1', 'FGF1', 'IGF1R', 'GYS2', 'GHR', 'CASP9', 'CCND2', 'CCND1', 'AKT3', 'RAC1', 'HRAS', 'HSP90AA1', 'PPP2R5B', 'PPP2R5D', 'CREB3', 'COL4A2', 'CCNE2', 'PIK3CA', 'COL4A1', 'CDC37', 'SGK3', 'EIF4E2', 'SGK2', 'ATF4', 'IFNAR1', 'LPAR1', 'PDGFA', 'EFNA5', 'HSP90B1', 'PPP2CB', 'GNG10', 'GNG3', 'RELN', 'GNG4', 'PPP2R3C', 'PDGFC', 'EIF4EBP1', 'FGF22', 'EIF4B', 'MAPK3', 'NTRK2', 'IGF1', 'NFKB1', 'CDK6', 'PPP2R2B', 'ITGA10', 'GNB1', 'GNB4', 'GRB2', 'GNB5', 'FGF12', 'FGFR2', 'FGFR1']",0.9998767371841938,0,0,57
395,BMP Signaling Pathway in Eyelid Development WP3927,0.8449413374317547,0.6289604250498105,0.10597233264685085,"['SFRP1', 'FGFR2', 'MAPK3']",0.9998767371841938,0,0,3
396,Globo Sphingolipid Metabolism WP1424,0.8449413374317547,0.6289604250498105,0.10597233264685085,"['B3GALNT1', 'ST8SIA1', 'ST6GALNAC4']",0.9998767371841938,0,0,3
397,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.8449413374317547,0.6289604250498105,0.10597233264685085,"['SETX', 'RBBP4', 'THRAP3']",0.9998767371841938,0,0,3
398,IL-5 signaling pathway WP127,0.8458229460994335,0.7064056939501779,0.11828426025823262,"['GSK3A', 'STAT1', 'PTPN11', 'GRB2', 'FOS', 'MAPT', 'MAPK3']",0.9998767371841938,0,0,7
399,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.846110770670314,0.7781619654231119,0.13003475005617834,"['HDAC5', 'CAMK2D', 'ROCK2', 'IGF1', 'RHOA', 'NFKB1', 'IGF1R', 'PPP3CA', 'PIK3CA', 'RAC1', 'MAP2K7', 'CALM1', 'CALM2', 'PRKG1', 'FGFR2', 'MAPK3']",0.9998767371841938,0,0,16
400,Benzo(a)pyrene metabolism WP696,0.8466363675378146,0.545228426395939,0.0907718064234958,['AKR1A1'],0.9998767371841938,0,0,1
401,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.8466363675378146,0.545228426395939,0.0907718064234958,['STAR'],0.9998767371841938,0,0,1
402,Drug Induction of Bile Acid Pathway WP2289,0.8466363675378146,0.545228426395939,0.0907718064234958,['ABCC4'],0.9998767371841938,0,0,1
403,exRNA mechanism of action and biogenesis WP2805,0.8466363675378146,0.545228426395939,0.0907718064234958,['XPO5'],0.9998767371841938,0,0,1
404,Fluoroacetic acid toxicity WP4966,0.8466363675378146,0.545228426395939,0.0907718064234958,['ALDH3A2'],0.9998767371841938,0,0,1
405,Irinotecan pathway WP229,0.8466363675378146,0.545228426395939,0.0907718064234958,['CES2'],0.9998767371841938,0,0,1
406,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.8466363675378146,0.545228426395939,0.0907718064234958,['HIF1AN'],0.9998767371841938,0,0,1
407,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.8466363675378146,0.545228426395939,0.0907718064234958,['CTDSP1'],0.9998767371841938,0,0,1
408,Small Ligand GPCRs WP247,0.8466363675378146,0.545228426395939,0.0907718064234958,['LPAR1'],0.9998767371841938,0,0,1
409,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.8466363675378146,0.545228426395939,0.0907718064234958,['IGF1R'],0.9998767371841938,0,0,1
410,Tamoxifen metabolism WP691,0.8466363675378146,0.545228426395939,0.0907718064234958,['SULT1A1'],0.9998767371841938,0,0,1
411,Regulation of Actin Cytoskeleton WP51,0.8468732412711446,0.8223894427402862,0.13668462189059805,"['CYFIP2', 'CHRM1', 'ROCK2', 'PXN', 'PDGFA', 'BRK1', 'FGF1', 'ACTG1', 'CDC42', 'CFL2', 'TMSB4X', 'RAC3', 'RAC1', 'MAPK6', 'FGF22', 'MAPK3', 'BRAF', 'ARPC5', 'SSH2', 'RHOA', 'DIAPH3', 'MRAS', 'PIK3CA', 'FGF12', 'CRK', 'VCL', 'FGFR2', 'FGFR1', 'ARHGEF6']",0.9998767371841938,0,0,29
412,Prolactin Signaling Pathway WP2037,0.848419346753876,0.7708407424139024,0.1267109960601922,"['STAT1', 'PXN', 'PTPN11', 'FOS', 'NFKB1', 'NFKBIA', 'PIK3CA', 'EIF4EBP1', 'GRB2', 'RAC1', 'PPIB', 'CTSD', 'HRAS', 'MAPK3', 'NFKBIB']",0.9998767371841938,0,0,15
413,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8533897049114886,0.7211417629106577,0.11432907369710246,"['ADCY3', 'BANF1', 'GRB2', 'ADCY8', 'LEMD3', 'HRAS', 'EMD', 'RHOA', 'MAPK3']",0.9998767371841938,0,0,9
414,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8533897049114886,0.7211417629106577,0.11432907369710246,"['MECP2', 'BECN1', 'MAP1LC3A', 'ATG16L1', 'WIPI1', 'WIPI2', 'PLA2G6', 'WDR45', 'GTPBP2']",0.9998767371841938,0,0,9
415,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8547434112377746,0.6811944091486658,0.1069161592971151,"['STAR', 'PIK3CA', 'PLCB1', 'HRAS', 'NFKB1', 'MAPK3']",0.9998767371841938,0,0,6
416,Lung fibrosis WP3624,0.8547434112377746,0.6811944091486658,0.1069161592971151,"['MECP2', 'FAM13A', 'PDGFA', 'ATP11A', 'IGF1', 'FGF1']",0.9998767371841938,0,0,6
417,Angiogenesis WP1539,0.8551295268512703,0.6412168118453884,0.10035192388736248,"['FLT1', 'PIK3CA', 'TIMP2', 'FGFR2']",0.9998767371841938,0,0,4
418,IL-7 signaling pathway WP205,0.8551295268512703,0.6412168118453884,0.10035192388736248,"['CDKN1B', 'CCND1', 'STAT1', 'MAPK3']",0.9998767371841938,0,0,4
419,Microglia Pathogen Phagocytosis Pathway WP3937,0.8551295268512703,0.6412168118453884,0.10035192388736248,"['VAV3', 'PIK3CA', 'RAC3', 'RAC1']",0.9998767371841938,0,0,4
420,NRF2-ARE regulation WP4357,0.8551295268512703,0.6412168118453884,0.10035192388736248,"['AIMP2', 'PIK3CA', 'KEAP1', 'RBX1']",0.9998767371841938,0,0,4
421,Ciliopathies WP4803,0.8569402367488292,0.8322148929684324,0.1284832424305064,"['GALNT11', 'C2CD3', 'ARL6', 'ARL3', 'PKD1L1', 'CCDC28B', 'GLI3', 'DYNC2LI1', 'TCTN3', 'CSPP1', 'TTC21B', 'TCTEX1D2', 'TMEM107', 'TCTN1', 'BBS9', 'RAB28', 'IFT57', 'DNAI1', 'BBS4', 'DYNC2H1', 'MKKS', 'DNAAF1', 'WDR19', 'LCA5', 'CFAP410', 'KIF7', 'POMGNT1', 'TTLL5', 'RSPH1', 'TMEM17', 'IFT43', 'TMEM138', 'NME7', 'CEP83', 'CEP41', 'CLUAP1', 'TRIM32']",0.9998767371841938,0,0,37
422,Glioblastoma signaling pathways WP2261,0.8592735991631587,0.771585117227319,0.1170246934675473,"['CDKN1B', 'GAB1', 'BRAF', 'PRKCZ', 'IGF1R', 'CCND2', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'NF1', 'GRB2', 'MAP2K7', 'HRAS', 'FGFR2', 'MAPK3', 'FGFR1']",0.9998767371841938,0,0,17
423,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8640413412684234,0.7564951604686704,0.11055016505819955,"['WNT10B', 'CSNK2A1', 'CTNNBIP1', 'CSNK1E', 'SENP2', 'NKD1', 'CDK8', 'SFRP1', 'CCND2', 'FRAT2', 'CDK6', 'HNRNPK', 'CCND1', 'CSNK2B', 'ROR1']",0.9998767371841938,0,0,15
424,Nanoparticle-mediated activation of receptor signaling WP2643,0.8658824197327502,0.6487732288037166,0.09342733725066608,"['MAPK10', 'PXN', 'AKT3', 'GRB2', 'HRAS']",0.9998767371841938,0,0,5
425,White fat cell differentiation WP4149,0.8658824197327502,0.6487732288037166,0.09342733725066608,"['WNT10B', 'TLE3', 'CEBPD', 'DDIT3', 'PPARG']",0.9998767371841938,0,0,5
426,Thermogenesis WP4321,0.866020330298853,0.7832436399217221,0.11266716531761758,"['SMARCD1', 'PRKAB2', 'PRKAG1', 'ADCY3', 'SIRT6', 'ARID1A', 'ADCY8', 'CPT1B', 'ARID1B', 'ACTG1', 'CREB3', 'RPS6KA6', 'ZNF516', 'PRKG2', 'GRB2', 'PPARG', 'PRKACA', 'HRAS', 'PRKG1', 'MGLL', 'FGFR1']",0.9998767371841938,0,0,21
427,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8672119458638492,0.68111337061515,0.09703949775923158,"['MAP1LC3A', 'EIF2B2', 'ILK', 'RICTOR', 'IGF1', 'NFKB1', 'IGF1R']",0.9998767371841938,0,0,7
428,Netrin-UNC5B signaling pathway WP4747,0.8672119458638492,0.68111337061515,0.09703949775923158,"['ARHGEF12', 'PIK3CA', 'NTN4', 'PTPN11', 'RAC1', 'RHOA', 'MAPK3']",0.9998767371841938,0,0,7
429,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8720273530957146,0.7004723150704839,0.09591881735730753,"['TGFBR3', 'STAT1', 'FOS', 'HRAS', 'RUNX2', 'NFKB1', 'ENG', 'MAPK3', 'FBN1']",0.9998767371841938,0,0,9
430,Dopaminergic Neurogenesis WP2855,0.8729772335772817,0.5451129728357451,0.07405130889868065,"['SOX2', 'ASCL1']",0.9998767371841938,0,0,2
431,FOXA2 pathway WP5066,0.8729772335772817,0.5451129728357451,0.07405130889868065,"['ABCC4', 'SLC27A5']",0.9998767371841938,0,0,2
432,Imatinib and Chronic Myeloid Leukemia WP3640,0.8741562945194665,0.5839802655445113,0.0785430638904454,"['CDKN1B', 'FLT1', 'GADD45A']",0.9998767371841938,0,0,3
433,Nicotine Activity on Dopaminergic Neurons WP1602,0.8741562945194665,0.5839802655445113,0.0785430638904454,"['CHRNA4', 'GNB1', 'PRKACA']",0.9998767371841938,0,0,3
434,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8741562945194665,0.5839802655445113,0.0785430638904454,"['GSK3A', 'BAX', 'BCL2L2']",0.9998767371841938,0,0,3
435,MAPK Cascade WP422,0.8763053216652888,0.6538856416772554,0.08633952311612268,"['MAPK10', 'BRAF', 'GRB2', 'MAP2K7', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,6
436,IL-3 signaling pathway WP286,0.8784889534761529,0.6810322908721078,0.08822905839119943,"['YWHAQ', 'YWHAB', 'PTPN11', 'GRB2', 'FOS', 'PRKACA', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,8
437,TGF-beta Receptor Signaling WP560,0.8784889534761529,0.6810322908721078,0.08822905839119943,"['TGFBR3', 'STAT1', 'FOS', 'HRAS', 'RUNX2', 'NFKB1', 'ENG', 'MAPK3']",0.9998767371841938,0,0,8
438,EPO Receptor Signaling WP581,0.8800282196814118,0.6055372110744222,0.07738844531952163,"['STAT1', 'RASA1', 'GRB2', 'MAPK3']",0.9998767371841938,0,0,4
439,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8848196098609259,0.7224998960887817,0.08841338549737758,"['WNT10B', 'CSNK2A1', 'CTNNBIP1', 'CSNK1E', 'SENP2', 'ELAVL1', 'NKD1', 'SFRP1', 'FRAT2', 'CCND2', 'CCND1', 'CSNK2B', 'ROR1']",0.9998767371841938,0,0,13
440,Cardiac Progenitor Differentiation WP2406,0.8874027702454192,0.6192257945306726,0.07397043360307821,"['SOX2', 'MESP1', 'BMP1', 'THY1', 'IGF1']",0.9998767371841938,0,0,5
441,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8874027702454192,0.6192257945306726,0.07397043360307821,"['RAP1A', 'YWHAQ', 'RAC1', 'TEAD1', 'RHOA']",0.9998767371841938,0,0,5
442,Glial Cell Differentiation WP2276,0.8878052583215644,0.4543147208121827,0.05406475281246729,['TPPP'],0.9998767371841938,0,0,1
443,Insulin signaling in adipocytes (diabetic condition) WP3635,0.8878052583215644,0.4543147208121827,0.05406475281246729,['TBC1D4'],0.9998767371841938,0,0,1
444,Insulin signaling in adipocytes (normal condition) WP3634,0.8878052583215644,0.4543147208121827,0.05406475281246729,['TBC1D4'],0.9998767371841938,0,0,1
445,Ketogenesis and Ketolysis WP4742,0.8878052583215644,0.4543147208121827,0.05406475281246729,['SLC16A1'],0.9998767371841938,0,0,1
446,Liver X receptor pathway WP2874,0.8878052583215644,0.4543147208121827,0.05406475281246729,['ABCG8'],0.9998767371841938,0,0,1
447,LTF danger signal response pathway WP4478,0.8878052583215644,0.4543147208121827,0.05406475281246729,['NFKB1'],0.9998767371841938,0,0,1
448,Mevalonate pathway WP3963,0.8878052583215644,0.4543147208121827,0.05406475281246729,['PMVK'],0.9998767371841938,0,0,1
449,Role of Osx and miRNAs in tooth development WP3971,0.8878052583215644,0.4543147208121827,0.05406475281246729,['RUNX2'],0.9998767371841938,0,0,1
450,Joubert Syndrome WP4656,0.8914820154505386,0.7293410232151954,0.08377941445285611,"['MRE11', 'PARP1', 'CETN2', 'ARL3', 'RHOA', 'TMEM17', 'KAT5', 'TCTN3', 'TMEM138', 'CSPP1', 'TCTN1', 'BBS9', 'CEP41', 'BBS4', 'ATF4']",0.9998767371841938,0,0,15
451,Non-small cell lung cancer WP4255,0.8914820154505386,0.7293410232151954,0.08377941445285611,"['GADD45A', 'CRABP1', 'BRAF', 'CASP9', 'RXRB', 'RASSF1', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'CYCS', 'BAX', 'GRB2', 'HRAS', 'MAPK3']",0.9998767371841938,0,0,15
452,Development of ureteric collection system WP5053,0.8951112688539021,0.6286775486267228,0.06966202759230594,"['GRIP1', 'CCND1', 'ILK', 'SLIT2', 'GLI3', 'FGFR2']",0.9998767371841938,0,0,6
453,Kit receptor signaling pathway WP304,0.8979280922053845,0.6808700076316458,0.07330606640268768,"['STAT1', 'MITF', 'PTPN11', 'GRB2', 'FOS', 'MAPT', 'JUNB', 'HRAS', 'CRK', 'MAPK3']",0.9998767371841938,0,0,10
454,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8979280922053845,0.6808700076316458,0.07330606640268768,"['RXRB', 'IFI27L2', 'CAMK2D', 'STAT1', 'ISG15', 'PLCB1', 'HRAS', 'PRKCZ', 'NFKB1', 'MAPK3']",0.9998767371841938,0,0,10
455,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8983784723592031,0.5449974606399187,0.0584040196071457,"['ACOX1', 'ACOX3', 'PLA2G6']",0.9998767371841938,0,0,3
456,miRNAs involvement in the immune response in sepsis WP4329,0.8983784723592031,0.5449974606399187,0.0584040196071457,"['NFKBIA', 'TAB2', 'NFKB1']",0.9998767371841938,0,0,3
457,Integrated breast cancer pathway WP1984,0.8988176614061978,0.7849163109965974,0.08373101723843523,"['GSK3A', 'MRE11', 'ZMYND8', 'TRADD', 'ODC1', 'PHB', 'CASP9', 'CDC42', 'RAP1A', 'CCND1', 'CDH1', 'ZMIZ1', 'DAG1', 'FADD', 'RAC1', 'RPP38', 'RALGAPA1', 'GADD45A', 'STAT1', 'NCOA3', 'DCAKD', 'BRAF', 'NFKB1', 'PML', 'FER', 'MSH2', 'NF1', 'BAX', 'FAU', 'MAP3K13']",0.9998767371841938,0,0,30
458,GPR40 Pathway WP3958,0.9007712152332179,0.4955110895704955,0.051782879397381396,"['PLCL1', 'PLCB1']",0.9998767371841938,0,0,2
459,Tryptophan catabolism leading to NAD+ production WP4210,0.9007712152332179,0.4955110895704955,0.051782879397381396,"['QPRT', 'KMO']",0.9998767371841938,0,0,2
460,Cannabinoid receptor signaling WP3869,0.9011184862298475,0.5736133577530313,0.0597237765977858,"['MAPK10', 'PRKAR1A', 'PRKACA', 'MAPK3']",0.9998767371841938,0,0,4
461,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9011184862298475,0.5736133577530313,0.0597237765977858,"['CBX5', 'RBBP4', 'H3F3B', 'H3F3A']",0.9998767371841938,0,0,4
462,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9011184862298475,0.5736133577530313,0.0597237765977858,"['PIK3CA', 'CBLB', 'NFKB1', 'RHOA']",0.9998767371841938,0,0,4
463,MTHFR deficiency WP4288,0.9011184862298475,0.5736133577530313,0.0597237765977858,"['CASP9', 'EHMT2', 'CYCS', 'HNMT']",0.9998767371841938,0,0,4
464,Sleep regulation WP3591,0.9011184862298475,0.5736133577530313,0.0597237765977858,"['AHCY', 'STAR', 'CRH', 'FOS']",0.9998767371841938,0,0,4
465,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9019638723474656,0.6952556819720247,0.07173704619692788,"['SCARB2', 'CDKN1B', 'PCNA', 'JAG1', 'YWHAQ', 'CDH2', 'MME', 'CTSL', 'DAG1', 'FAT1', 'ILK', 'VCL']",0.9998767371841938,0,0,12
466,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9040366123690452,0.7644380300926191,0.07712065096683819,"['SPARC', 'PDCD6', 'EIF5A2', 'WNT8A', 'DLL1', 'DLL3', 'CDH2', 'RBBP4', 'CDH1', 'AKT3', 'HRAS', 'MEF2D', 'MAPK3', 'WNT10B', 'JAG1', 'TJP1', 'FMNL2', 'COL4A2', 'PIK3CA', 'COL4A1', 'CTDSP1', 'ID2', 'CLDN12', 'STRAP', 'GRB2']",0.9998767371841938,0,0,25
467,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9058830208566825,0.592247702368328,0.05854078178263278,"['CDKN1B', 'PIK3CA', 'EIF4EBP1', 'RICTOR', 'HRAS']",0.9998767371841938,0,0,5
468,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9058830208566825,0.592247702368328,0.05854078178263278,"['CASP9', 'PIK3CA', 'BAX', 'BRAF', 'NOS1']",0.9998767371841938,0,0,5
469,"GPCRs, Other WP117",0.9098739149780275,0.6408519166629275,0.06052797907044239,"['EDNRA', 'ADGRV1', 'CCKBR', 'GPR61', 'SSTR2', 'CELSR2', 'ADGRL2', 'ADGRL3']",0.9998767371841938,0,0,8
470,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9098739149780275,0.6408519166629275,0.06052797907044239,"['HSP90AA1', 'CCND1', 'BAX', 'TRAF2', 'FOS', 'CFLAR', 'MAP2K7', 'JUNB']",0.9998767371841938,0,0,8
471,Cell cycle WP179,0.9101286760623215,0.7422773654916512,0.0698997304140166,"['YWHAE', 'CDKN2D', 'CDKN1B', 'PCNA', 'PRKDC', 'GADD45A', 'YWHAB', 'RBX1', 'ANAPC11', 'STAG1', 'CCND2', 'ORC6', 'CDK6', 'CCND1', 'CCNE2', 'YWHAQ', 'ORC3', 'MCM4', 'MCM6', 'SKP1', 'YWHAH']",0.9998767371841938,0,0,21
472,Notch Signaling Pathway Netpath WP61,0.9111738805265319,0.6642013761780966,0.06178502968696613,"['NUMBL', 'JAG1', 'CCND1', 'PSEN2', 'CIR1', 'MAPT', 'DLL1', 'NFKB1', 'SKP1', 'DLL3']",0.9998767371841938,0,0,10
473,Type 2 papillary renal cell carcinoma WP4241,0.9114151179983242,0.6053367217280813,0.05614910487202586,"['EGLN2', 'CUL2', 'ELOB', 'ELOC', 'VHL', 'RBX1']",0.9998767371841938,0,0,6
474,Allograft Rejection WP2328,0.9171416375859524,0.6150269773849156,0.053195750434596116,"['CASP9', 'STAT1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PRKCZ']",0.9998767371841938,0,0,7
475,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.9179247004123424,0.3893763596809282,0.0333461592885906,['ADH5'],0.9998767371841938,0,0,1
476,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.9179247004123424,0.3893763596809282,0.0333461592885906,['CCND1'],0.9998767371841938,0,0,1
477,Nephrogenesis WP5052,0.9179247004123424,0.3893763596809282,0.0333461592885906,['JAG1'],0.9998767371841938,0,0,1
478,Selective expression of chemokine receptors during T-cell polarization WP4494,0.9179247004123424,0.3893763596809282,0.0333461592885906,['IFNGR2'],0.9998767371841938,0,0,1
479,Valproic acid pathway WP3871,0.9179247004123424,0.3893763596809282,0.0333461592885906,['HSD17B10'],0.9998767371841938,0,0,1
480,NAD+ biosynthetic pathways WP3645,0.9183129595920464,0.5108875063484002,0.04353631691126068,"['PARP1', 'QPRT', 'SIRT6']",0.9998767371841938,0,0,3
481,Ovarian infertility WP34,0.9183129595920464,0.5108875063484002,0.04353631691126068,"['EGR1', 'CDKN1B', 'CCND2']",0.9998767371841938,0,0,3
482,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9188606032635634,0.5448818897637795,0.04610836931318582,"['BMP2', 'THRA', 'STAT1', 'MAPK3']",0.9998767371841938,0,0,4
483,Vitamin B12 metabolism WP1533,0.9188606032635634,0.5448818897637795,0.04610836931318582,"['MMAB', 'APOA1', 'NFKB1', 'SOD1']",0.9998767371841938,0,0,4
484,Hepatitis B infection WP4666,0.9209799365035185,0.7474968851373346,0.061531721600450326,"['PCNA', 'YWHAB', 'CASP9', 'YWHAQ', 'AKT3', 'FADD', 'MAP2K7', 'HRAS', 'MAPK3', 'EGR3', 'ATP6AP1', 'STAT1', 'BRAF', 'FOS', 'NFKB1', 'DDB1', 'MAPK10', 'CREB3', 'PIK3CA', 'CYCS', 'BAX', 'GRB2', 'TAB2', 'IFNAR1', 'ATF4']",0.9998767371841938,0,0,25
485,Differentiation of white and brown adipocyte WP2895,0.9227987559703459,0.45417618684945416,0.03649037733113804,"['BMP2', 'PPARG']",0.9998767371841938,0,0,2
486,Fatty acid transporters WP5061,0.9227987559703459,0.45417618684945416,0.03649037733113804,"['FABP5', 'FABP6']",0.9998767371841938,0,0,2
487,Hypertrophy Model WP516,0.9227987559703459,0.45417618684945416,0.03649037733113804,"['WDR1', 'EIF4EBP1']",0.9998767371841938,0,0,2
488,Type II diabetes mellitus WP1584,0.9227987559703459,0.45417618684945416,0.03649037733113804,"['SURF1', 'PRKCZ']",0.9998767371841938,0,0,2
489,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9254705392815357,0.5836630967507714,0.045206445980776284,"['MAPK10', 'DDIT3', 'FOS', 'MAP2K7', 'JUNB', 'MAPK3']",0.9998767371841938,0,0,6
490,Glucocorticoid Receptor Pathway WP2880,0.928206783706011,0.6283942405509039,0.0468158382885278,"['TGFBR3', 'FGD4', 'RGS2', 'HSP90AA1', 'NAV3', 'PLK2', 'PTGES3', 'PDE4B', 'BIRC2']",0.9998767371841938,0,0,9
491,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.928206783706011,0.6283942405509039,0.0468158382885278,"['WNT10B', 'BMP2', 'FNTA', 'CEBPD', 'PPARG', 'LEMD3', 'JUNB', 'EMD', 'RUNX2']",0.9998767371841938,0,0,9
492,Wnt Signaling Pathway WP363,0.928206783706011,0.6283942405509039,0.0468158382885278,"['BCL9', 'GSK3A', 'CDK6', 'CCND1', 'PPARG', 'ROR1', 'RAC1', 'CSNK1E', 'RHOA']",0.9998767371841938,0,0,9
493,B Cell Receptor Signaling Pathway WP23,0.9301422762756272,0.6912465878070974,0.05005850135824814,"['KLF11', 'GSK3A', 'CD81', 'GAB1', 'BRAF', 'PTPN11', 'ILF2', 'NFKB1', 'NFKBIA', 'CDC42', 'BLNK', 'GRB2', 'RAC1', 'HRAS', 'CRK', 'MEF2D']",0.9998767371841938,0,0,16
494,T-cell receptor (TCR) signaling pathway WP69,0.930519579318538,0.6677218230027283,0.048084091690558814,"['VAV3', 'CD83', 'ITPR1', 'CBLB', 'PTPN11', 'FOS', 'NFKB1', 'CDC42', 'NFKBIA', 'GRB2', 'HRAS', 'CRK', 'MAPK3']",0.9998767371841938,0,0,13
495,MAPK Signaling Pathway WP382,0.9309801650313136,0.7935364807140783,0.056751592064653245,"['RASGRF1', 'PDGFA', 'FGF1', 'DUSP16', 'CDC42', 'PPP3CA', 'RAP1A', 'STMN1', 'AKT3', 'RAC3', 'RAC1', 'PRKACA', 'MAP2K7', 'HRAS', 'CACNG3', 'MAP4K3', 'FGF22', 'MAPK3', 'HSPA8', 'NTRK2', 'DUSP3', 'GADD45A', 'DUSP1', 'PLA2G4C', 'BRAF', 'TRAF2', 'FOS', 'HSPA2', 'NFKB1', 'MAPK10', 'NR4A1', 'MRAS', 'CACNB4', 'DDIT3', 'RASA1', 'NF1', 'RAPGEF2', 'GRB2', 'TAB2', 'MAPT', 'MAP3K13', 'FGF12', 'CRK', 'PTPN5', 'FGFR2', 'ATF4', 'FGFR1']",0.9998767371841938,0,0,47
496,22q11.2 copy number variation syndrome WP4657,0.9333465591723396,0.6997851498488766,0.04827027064754825,"['RANBP1', 'CBX5', 'TXNRD2', 'EMC10', 'RBX1', 'CDC42', 'MRPL40', 'XPO1', 'HIRIP3', 'RELN', 'POLR2A', 'THAP7', 'HIST1H4C', 'KPNB1', 'FGFR2', 'RAN', 'FGFR1', 'DGCR2']",0.9998767371841938,0,0,18
497,Wnt signaling WP428,0.9333465591723396,0.6997851498488766,0.04827027064754825,"['WNT10B', 'CAMK2D', 'CSNK2A1', 'ROCK2', 'CTNNBIP1', 'CSNK1E', 'SENP2', 'RHOA', 'NKD1', 'PPP3CA', 'SFRP1', 'CCND2', 'FRAT2', 'CCND1', 'CSNK2B', 'ROR1', 'RAC1', 'PLCB1']",0.9998767371841938,0,0,18
498,Signal transduction through IL1R WP4496,0.9336930227018555,0.5188867520592184,0.03559955618610603,"['NFKBIA', 'TOLLIP', 'IL1RAP', 'NFKB1']",0.9998767371841938,0,0,4
499,IL-4 signaling pathway WP395,0.9340638958795815,0.6051360284769896,0.04127658997397465,"['NFKBIA', 'PIK3CA', 'STAT1', 'PTPN11', 'GRB2', 'FOS', 'NFKB1', 'MAPK3']",0.9998767371841938,0,0,8
500,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9346111047913389,0.48079048785588385,0.03251334467912094,"['EIF4EBP1', 'PRKACA', 'MAPK3']",0.9998767371841938,0,0,3
501,Blood Clotting Cascade WP272,0.9399597329690119,0.3406725888324873,0.02109384776492788,['KLKB1'],0.9998767371841938,0,0,1
502,Cytokines and Inflammatory Response WP530,0.9399597329690119,0.3406725888324873,0.02109384776492788,['PDGFA'],0.9998767371841938,0,0,1
503,Estrogen Receptor Pathway WP2881,0.9399597329690119,0.3406725888324873,0.02109384776492788,['ACOX1'],0.9998767371841938,0,0,1
504,Farnesoid X receptor pathway WP2879,0.9399597329690119,0.3406725888324873,0.02109384776492788,['SLC27A5'],0.9998767371841938,0,0,1
505,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.9399597329690119,0.3406725888324873,0.02109384776492788,['APOA1'],0.9998767371841938,0,0,1
506,Canonical and non-canonical TGF-B signaling WP3874,0.940152488224781,0.41920049993165,0.025870202346809597,"['BMP1', 'LOXL2']",0.9998767371841938,0,0,2
507,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.940152488224781,0.41920049993165,0.025870202346809597,"['ACOX1', 'ACOX3']",0.9998767371841938,0,0,2
508,Eicosanoid Synthesis WP167,0.940152488224781,0.41920049993165,0.025870202346809597,"['PTGES2', 'PLA2G6']",0.9998767371841938,0,0,2
509,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.940152488224781,0.41920049993165,0.025870202346809597,"['RHOA', 'FGFR2']",0.9998767371841938,0,0,2
510,PPAR-alpha pathway WP2878,0.940152488224781,0.41920049993165,0.025870202346809597,"['CCND1', 'APOA1']",0.9998767371841938,0,0,2
511,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9425100643433526,0.6187414722138711,0.03663486667784935,"['ACTR2', 'CDKN1B', 'ROCK2', 'ERBB4', 'TMSB4X', 'PFN4', 'GRB2', 'NOS1', 'RHOA', 'SOD1']",0.9998767371841938,0,0,10
512,Genes controlling nephrogenesis WP4823,0.9460221691111346,0.49525480869143557,0.027481330584817634,"['ILK', 'SLIT2', 'GLI3', 'FGFR2']",0.9998767371841938,0,0,4
513,Glycerophospholipid Biosynthetic Pathway WP2533,0.9460221691111346,0.49525480869143557,0.027481330584817634,"['PGS1', 'PIK3CA', 'PTPMT1', 'CDIPT']",0.9998767371841938,0,0,4
514,Vitamin A and carotenoid metabolism WP716,0.9463307943737601,0.5237648530331457,0.028892489887298377,"['RXRB', 'SULT1A1', 'ABCG8', 'RBP4', 'CRABP1']",0.9998767371841938,0,0,5
515,Notch Signaling WP268,0.9478097115733292,0.5446505717916137,0.029194100185591428,"['NUMBL', 'JAG1', 'PSEN2', 'DTX4', 'DLL1', 'DLL3']",0.9998767371841938,0,0,6
516,TLR4 Signaling and Tolerance WP3851,0.9478579714858789,0.4540375825292026,0.024313988171967647,"['NFKBIA', 'TAB2', 'NFKB1']",0.9998767371841938,0,0,3
517,Focal Adhesion WP306,0.9523820503002169,0.7433075716845878,0.036265241555079236,"['FLT1', 'ROCK2', 'PXN', 'RASGRF1', 'PDGFA', 'ILK', 'LAMC1', 'MYL12B', 'ACTG1', 'IGF1R', 'CDC42', 'RELN', 'CCND2', 'RAP1A', 'CCND1', 'AKT3', 'PDGFC', 'RAC3', 'RAC1', 'HRAS', 'MAPK3', 'VAV3', 'BRAF', 'PARVB', 'IGF1', 'RHOA', 'MAPK10', 'COL4A2', 'PIK3CA', 'COL4A1', 'ITGA10', 'GRB2', 'CRK', 'VCL', 'BIRC2']",0.9998767371841938,0,0,35
518,Glycosaminoglycan degradation WP4815,0.9537540052979729,0.3892213397163892,0.01842943460517311,"['HPSE2', 'HEXB']",0.9998767371841938,0,0,2
519,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9537540052979729,0.3892213397163892,0.01842943460517311,"['ACADL', 'ACADS']",0.9998767371841938,0,0,2
520,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.9537540052979729,0.3892213397163892,0.01842943460517311,"['BMP2', 'CDC37']",0.9998767371841938,0,0,2
521,Transcription factor regulation in adipogenesis WP3599,0.9537540052979729,0.3892213397163892,0.01842943460517311,"['CEBPD', 'PPARG']",0.9998767371841938,0,0,2
522,ErbB signaling pathway WP673,0.9555197427144372,0.6607397699140818,0.030063562622869532,"['CAMK2D', 'CDKN1B', 'GAB1', 'CBLB', 'BRAF', 'MAPK10', 'CCND1', 'NRG3', 'PIK3CA', 'ERBB4', 'AKT3', 'EIF4EBP1', 'GRB2', 'MAP2K7', 'HRAS', 'CRK', 'MAPK3']",0.9998767371841938,0,0,17
523,Fatty acid beta-oxidation WP143,0.9558158449698951,0.5043191056910569,0.022790188087664594,"['GCDH', 'ECHS1', 'ACADL', 'ACADS', 'CPT1B']",0.9998767371841938,0,0,5
524,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.9560798970399492,0.30279187817258885,0.013599532378216006,['MAFF'],0.9998767371841938,0,0,1
525,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.9560798970399492,0.30279187817258885,0.013599532378216006,['PMVK'],0.9998767371841938,0,0,1
526,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.9560798970399492,0.30279187817258885,0.013599532378216006,['MAPK3'],0.9998767371841938,0,0,1
527,Complement and Coagulation Cascades WP558,0.9562167943971718,0.47367781692085126,0.021206849192194694,"['CLTC', 'SERPING1', 'CLU', 'KLKB1']",0.9998767371841938,0,0,4
528,Oxidation by Cytochrome P450 WP43,0.9562167943971718,0.47367781692085126,0.021206849192194694,"['CYP4Z1', 'CYB5R1', 'CYB5R3', 'CYP20A1']",0.9998767371841938,0,0,4
529,Pathways in clear cell renal cell carcinoma WP4018,0.9569952956994486,0.6349376114081996,0.027909827638994345,"['FLT1', 'BHLHE41', 'PLOD2', 'ENO2', 'ACACB', 'LDHA', 'ME1', 'PGK1', 'VHL', 'ALDOA', 'GAPDH', 'SQSTM1', 'PFKM', 'KCNJ2']",0.9998767371841938,0,0,14
530,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9585678712095205,0.43010077250006684,0.018199675129345907,"['BCL9', 'CCND1', 'PML']",0.9998767371841938,0,0,3
531,Ectoderm Differentiation WP2858,0.9602974593924893,0.687346089336901,0.027845894666639552,"['ABCC4', 'GRAMD1B', 'SMURF1', 'CTNND2', 'ARX', 'HMGB2', 'RRBP1', 'LDB2', 'PTPN13', 'CELSR2', 'GLI3', 'WDR44', 'SOX2', 'MECP2', 'PLCXD3', 'ARHGEF9', 'MAFB', 'ZNF219', 'ST8SIA4', 'UBTF', 'FGFR2', 'ANKS1B', 'LY6E']",0.9998767371841938,0,0,23
532,Interleukin-11 Signaling Pathway WP2332,0.9639345948330872,0.5105146124523507,0.018752138181360994,"['STAT1', 'PTPN11', 'GRB2', 'HRAS', 'RUNX2', 'MAPK3']",0.9998767371841938,0,0,6
533,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9643669603279592,0.36323940086316325,0.013179557776673605,"['EIF4EBP1', 'MAPK3']",0.9998767371841938,0,0,2
534,Zinc homeostasis WP3529,0.9646057051883313,0.4538989077978156,0.016356636043470367,"['SLC30A9', 'SLC39A9', 'SLC39A7', 'SLC39A1']",0.9998767371841938,0,0,4
535,DNA damage response (only ATM dependent) WP710,0.9655735231868364,0.6422655453618756,0.022500507886189628,"['WNT10B', 'CDKN1B', 'NFKB1', 'RHOA', 'BBC3', 'CDC42', 'MAPK10', 'CCND2', 'CCND1', 'PIK3CA', 'CCNG2', 'AKT3', 'RAC3', 'BAX', 'GRB2', 'RAC1', 'HRAS']",0.9998767371841938,0,0,17
536,Hippo-Merlin Signaling Dysregulation WP4541,0.9655735231868364,0.6422655453618756,0.022500507886189628,"['NTRK2', 'FLT1', 'ITGAE', 'IGF1R', 'RBX1', 'DDB1', 'CCND1', 'CDH2', 'CDH1', 'PRKAR1A', 'ITGA10', 'PRKACA', 'HRAS', 'TEAD1', 'FGFR2', 'CDH18', 'FGFR1']",0.9998767371841938,0,0,17
537,Adipogenesis WP236,0.9663535822960561,0.6541257044003641,0.022387769169860215,"['NCOA1', 'GDF10', 'CNTFR', 'WNT10B', 'NCOA2', 'MBNL1', 'CEBPD', 'GADD45A', 'STAT1', 'MIF', 'IGF1', 'BSCL2', 'BMP2', 'BMP1', 'DDIT3', 'NDN', 'TRIB3', 'PPARG', 'MEF2D']",0.9998767371841938,0,0,19
538,Inflammatory Response Pathway WP453,0.9678726220073437,0.27248730964467005,0.008898015655990807,['LAMC1'],0.9998767371841938,0,0,1
539,Leptin Insulin Overlap WP3935,0.9678726220073437,0.27248730964467005,0.008898015655990807,['LEPR'],0.9998767371841938,0,0,1
540,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9690432042295228,0.5669676926990588,0.017828912372913577,"['RYR2', 'CACNB4', 'CDH2', 'SGCB', 'ITGA10', 'DAG1', 'ATP2A2', 'EMD', 'CACNG3', 'ACTG1']",0.9998767371841938,0,0,10
541,Bladder cancer WP2828,0.9703434150088477,0.4694508690776563,0.01413292828813727,"['RASSF1', 'CCND1', 'CDH1', 'BRAF', 'HRAS']",0.9998767371841938,0,0,5
542,Vitamin D-sensitive calcium signaling in depression WP4698,0.9703434150088477,0.4694508690776563,0.01413292828813727,"['GRM5', 'CHRM1', 'GPX4', 'ITPR1', 'ATP2B3']",0.9998767371841938,0,0,5
543,Differentiation Pathway WP2848,0.971477883605323,0.4357023114046228,0.012607820025165348,"['NT5E', 'PDGFA', 'IGF1', 'FGF1']",0.9998767371841938,0,0,4
544,Purinergic signaling WP4900,0.9726154512169214,0.3405052043665905,0.009454635929016068,"['GNAO1', 'GNAI2']",0.9998767371841938,0,0,2
545,Pathways affected in adenoid cystic carcinoma WP3651,0.9736511240192386,0.555345007501856,0.014828949229180481,"['MAGI1', 'MORF4L1', 'PIK3CA', 'PRKDC', 'MAGI2', 'JMJD1C', 'ARID5B', 'ARID1A', 'DTX4', 'HRAS']",0.9998767371841938,0,0,10
546,Monoamine GPCRs WP58,0.9740886793673843,0.3890662410215483,0.010214129921398698,"['CHRM1', 'HTR5A', 'ADRA2A']",0.9998767371841938,0,0,3
547,One-carbon metabolism and related pathways WP3940,0.9753770842364166,0.48039464832947154,0.011976781280358026,"['DMGDH', 'GPX4', 'GSS', 'BCAT1', 'CDO1', 'SOD1']",0.9998767371841938,0,0,6
548,ID signaling pathway WP53,0.9764993832656569,0.24769266266728196,0.005890418901656081,['ID2'],0.9998767371841938,0,0,1
549,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.9764993832656569,0.24769266266728196,0.005890418901656081,['NFKB1'],0.9998767371841938,0,0,1
550,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.9764993832656569,0.24769266266728196,0.005890418901656081,['DKK3'],0.9998767371841938,0,0,1
551,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9776272803079894,0.5441872297125413,0.01231320775416636,"['GHR', 'PTPRD', 'MAPK10', 'CNTFR', 'IFNGR2', 'STMN1', 'RICTOR', 'MAPK6', 'IFNAR1', 'MAPK3']",0.9998767371841938,0,0,10
552,Statin inhibition of cholesterol production WP430,0.9790039126016902,0.32044561922255577,0.006799740657310613,"['ABCG8', 'APOA1']",0.9998767371841938,0,0,2
553,Hematopoietic Stem Cell Differentiation WP2849,0.9795971230012559,0.37134678424673345,0.007654902066887393,"['ZNF835', 'FOSB', 'FOS']",0.9998767371841938,0,0,3
554,Wnt signaling in kidney disease WP4150,0.9795971230012559,0.37134678424673345,0.007654902066887393,"['MAPK10', 'WNT10B', 'RHOA']",0.9998767371841938,0,0,3
555,Wnt signaling pathway and pluripotency WP399,0.9817546839258279,0.5768919137903095,0.010622780709517169,"['WNT10B', 'CSNK1E', 'PRKCZ', 'FBXW2', 'RHOA', 'NKD1', 'SOX2', 'MAPK10', 'PPP2CB', 'CCND2', 'CCND1', 'PPP2R2B', 'PRKD1', 'PAFAH1B1']",0.9998767371841938,0,0,14
556,Omega-9 FA synthesis WP4724,0.9828099770663701,0.22703045685279188,0.003936591589695151,['ACOT2'],0.9998767371841938,0,0,1
557,Ethanol effects on histone modifications WP3996,0.9839764119312993,0.3551681498001634,0.005737156793486707,"['HDAC5', 'AHCY', 'EHMT2']",0.9998767371841938,0,0,3
558,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9839764119312993,0.3551681498001634,0.005737156793486707,"['TGFBR3', 'PROM1', 'HRAS']",0.9998767371841938,0,0,3
559,Nephrotic syndrome WP4758,0.9840460939347361,0.4253207571138211,0.006840237917876191,"['SCARB2', 'YARS', 'ARHGDIA', 'TTC21B', 'WDR73']",0.9998767371841938,0,0,5
560,Prostaglandin Synthesis and Regulation WP98,0.9853293857434692,0.3889110635364128,0.005747830146637899,"['ABCC4', 'EDNRA', 'MITF', 'PPARG']",0.9998767371841938,0,0,4
561,ESC Pluripotency Pathways WP3931,0.9859735018524646,0.5799949044585987,0.00819289151657699,"['WNT10B', 'ACTR2', 'GAB1', 'PDGFA', 'BRAF', 'PTPN11', 'FOS', 'FGF1', 'AKT3', 'GRB2', 'MAPK6', 'FGF12', 'HRAS', 'FGF22', 'FGFR2', 'FGFR1']",0.9998767371841938,0,0,16
562,Phosphodiesterases in neuronal function WP4222,0.9860690156733606,0.4645864074299106,0.006517650754258251,"['PDE10A', 'PDE1C', 'PDE4D', 'PDE4B', 'ADCY3', 'NOS1', 'ADCY8']",0.9998767371841938,0,0,7
563,Kennedy pathway from sphingolipids WP3933,0.9874261431051964,0.20954705193283873,0.0026515197140310164,['SGPL1'],0.9998767371841938,0,0,1
564,Mammalian disorder of sexual development WP4842,0.9874261431051964,0.20954705193283873,0.0026515197140310164,['FGFR2'],0.9998767371841938,0,0,1
565,Riboflavin and CoQ disorders WP5037,0.9874261431051964,0.20954705193283873,0.0026515197140310164,['FLAD1'],0.9998767371841938,0,0,1
566,Neovascularisation processes WP4331,0.9874463133329231,0.34033773489080754,0.004299537631677843,"['JAG1', 'NFKB1', 'MAPK3']",0.9998767371841938,0,0,3
567,Gastric Cancer Network 1 WP2361,0.9877340492587271,0.28666105476944453,0.0035379129419856247,"['H3F3A', 'MCM4']",0.9998767371841938,0,0,2
568,Glycerolipids and Glycerophospholipids WP4722,0.9877340492587271,0.28666105476944453,0.0035379129419856247,"['DGAT2', 'CDIPT']",0.9998767371841938,0,0,2
569,Heart Development WP1591,0.9877340492587271,0.28666105476944453,0.0035379129419856247,"['BMP2', 'PTPN11']",0.9998767371841938,0,0,2
570,Toll-like Receptor Signaling related to MyD88 WP3858,0.9877340492587271,0.28666105476944453,0.0035379129419856247,"['TOLLIP', 'NFKB1']",0.9998767371841938,0,0,2
571,Cholesterol Biosynthesis Pathway WP197,0.9908027558394215,0.1945612762871646,0.001797707269399599,['PMVK'],0.9998767371841938,0,0,1
572,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9908027558394215,0.1945612762871646,0.001797707269399599,['PDHA1'],0.9998767371841938,0,0,1
573,TGF-beta Signaling Pathway WP366,0.9927726463311723,0.5780114712377976,0.004192662571322547,"['KLF11', 'UBE2I', 'SMURF1', 'WWP1', 'FOS', 'RUNX2', 'RHOA', 'PML', 'RBX1', 'TGFBR3', 'CDC42', 'CCND1', 'SUMO1', 'SNIP1', 'STRAP', 'FOSB', 'GRB2', 'RAC1', 'JUNB', 'SKP1']",0.9998767371841938,0,0,20
574,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9932726001582677,0.18157360406091372,0.0012256455772817457,['SIRT6'],0.9998767371841938,0,0,1
575,MECP2 and Associated Rett Syndrome WP3584,0.9933095283144138,0.47704481248912156,0.0032023795110867745,"['MECP2', 'PRPF38A', 'CEBPD', 'SST', 'NF1', 'TAP1', 'YBX1', 'IGF1', 'IGF1R', 'GRIA4']",0.9998767371841938,0,0,10
576,Endoderm differentiation WP2853,0.9933755735531753,0.5672285389266521,0.0037700648259073118,"['VAV3', 'STAT1', 'CTR9', 'WNT8A', 'RTF1', 'LAMC1', 'TRERF1', 'ELAVL1', 'NME1', 'SOX2', 'SFRP1', 'SESN1', 'TCEAL2', 'UBR5', 'NABP2', 'LEO1', 'CEBPZ', 'ASCC3', 'TOX']",0.9998767371841938,0,0,19
577,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.9950791343717715,0.17020939086294415,0.0008396451300393462,['PPARG'],0.9998767371841938,0,0,1
578,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9953056914327406,0.5599770729642396,0.002634894525109013,"['CAP1', 'ABCG8', 'PRKAB2', 'GSK3A', 'THRA', 'PRKAG1', 'CBLB', 'MAPK10', 'RPS6KA6', 'PIK3CA', 'EIF4EBP1', 'RICTOR', 'MAP2K7', 'MAP3K13', 'MAP4K5', 'MAPK6', 'HRAS', 'CRK', 'MAP4K3', 'MAPK3']",0.9998767371841938,0,0,20
579,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9973668768158089,0.15126903553299492,0.00039883532652685433,['TERF2'],0.9998767371841938,0,0,1
580,ATM Signaling Pathway WP2516,0.997849746704202,0.26331525745834633,0.0005668041050053643,"['NFKBIA', 'MRE11', 'GADD45A']",0.9998767371841938,0,0,3
581,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9986158656355092,0.2862986778605136,0.00039655034136642706,"['NR1H2', 'PMVK', 'ACOT2', 'TM7SF2']",0.9998767371841938,0,0,4
582,Mesodermal commitment pathway WP2857,0.9988875653847824,0.47730104290613845,0.0005312617538079255,"['VAV3', 'ARID5B', 'TRERF1', 'DLL1', 'SOX2', 'CCND1', 'PRKAR1A', 'SESN1', 'UBR5', 'NABP2', 'RPL38', 'ASCC3', 'PRKACA', 'TOX', 'TEAD1', 'FGFR1']",0.9998767371841938,0,0,16
583,"GPCRs, Class A Rhodopsin-like WP455",0.9989041066007268,0.4345533214558412,0.00047648525285109956,"['OPRD1', 'GPR173', 'EDNRA', 'CHRM1', 'CCKBR', 'GPR22', 'NPY1R', 'PRLHR', 'NMBR', 'SSTR2', 'HTR5A', 'ADRA2A']",0.9998767371841938,0,0,12
584,Phosphoinositides metabolism WP4971,0.9993396278592064,0.2652756525025245,0.00017523851823167072,"['PIK3CA', 'MTMR9', 'PLCB1', 'SBF2']",0.9998767371841938,0,0,4
585,TYROBP causal network in microglia WP3945,0.9998400470356837,0.10076142131979696,1.6118377154292095e-05,['ABCC4'],0.9998767371841938,0,0,1
586,Male infertility WP4673,0.9998767371841938,0.3640042201948737,4.487095066324489e-05,"['NANOS1', 'GNAO1', 'DDX4', 'MTHFD1', 'UBE2B', 'PARP1', 'XRCC5', 'MOV10L1', 'NOS1', 'CDC42BPA', 'CLU']",0.9998767371841938,0,0,11
